hg_54858.1

Basic information about the TSS

---

TSS ID: hg_54858.1 Species: human Chr: chr4		Start: 173333713 End: 173333774 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: NM_001130689 Distance: 0 GeneID: 3148 HGNC/MGI_ID: HGNC:5000 UniProt_ID: P26583

Gene_name: high mobility group box 2 Gene_symbol: HMGB2 Gene_synonyms: Gene_source: HGNC:5000

TATA-Box annotation

---

Distance to TSS:	25
Nearest PromoterID:	NM_001130689
Entrez ID:	3148
Nearest Unigene:	Hs.434953
Nearest Refseq:	NM_002129
Nearest Ensembl:	ENSG00000164104
Gene Name:	high mobility group box 2
Gene Alias:	HMG2
Gene Description:	high mobility group box 2
Gene Type:	protein-coding
CpG%:	0.135
GC%:	0.79602
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@HMGB2 p2@HMGB2 p3@HMGB2 p4@HMGB2 p5@HMGB2 p8@HMGB2
Sample		p1@HMGB2	p2@HMGB2	p3@HMGB2	p4@HMGB2	p5@HMGB2	p8@HMGB2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	144.15	5.06	2.14	0.97	0.00	3.90
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	148.50	3.84	1.42	2.43	0.20	4.05
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	163.20	3.67	0.96	2.70	0.58	3.86
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	146.78	2.08	1.04	1.46	0.83	2.29
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	160.85	5.17	0.45	0.67	0.22	3.37
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	164.55	5.62	0.78	0.78	0.00	2.71
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	217.88	8.50	2.40	1.74	0.65	5.23
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	179.48	5.09	0.97	1.21	0.48	3.39
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	144.05	5.34	0.85	0.43	0.64	2.99
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	324.59	19.13	1.16	1.16	0.58	9.85
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	259.92	14.55	0.81	0.40	0.81	7.28
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	301.26	10.98	1.22	2.03	0.81	8.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	75.76	8.54	0.64	0.64	0.48	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	77.13	7.22	1.20	0.45	0.60	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	79.70	6.15	1.54	0.44	0.44	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	75.45	7.80	0.50	0.75	0.25	1.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	77.32	6.77	1.31	0.66	0.66	1.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	71.71	8.86	1.27	0.42	1.27	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	78.37	2.67	0.00	0.53	0.53	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	85.30	6.02	0.75	0.30	0.75	1.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	86.87	8.55	0.67	0.40	0.40	3.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	81.65	6.21	0.69	1.38	0.69	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	72.77	7.11	0.90	0.13	0.39	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	71.34	5.82	0.73	0.73	0.24	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	59.34	6.19	0.52	0.00	1.03	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	68.68	8.23	1.27	0.63	0.32	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	67.58	8.24	0.55	0.00	0.55	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	68.84	6.37	1.18	0.47	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	52.33	4.04	1.29	0.16	0.32	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	57.00	4.52	1.27	0.54	0.18	2.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	42.50	3.14	0.21	0.42	0.00	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	42.40	2.74	0.78	0.00	0.00	1.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	41.15	3.17	0.42	0.63	0.21	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	51.96	4.29	1.81	0.33	0.82	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	33.47	4.86	0.37	0.00	0.56	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	33.15	2.49	0.38	0.57	0.57	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	30.25	1.02	0.41	0.20	0.00	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	31.43	2.01	0.20	0.00	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	39.71	1.89	0.00	0.27	0.00	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	36.97	2.88	0.96	0.00	0.24	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	24.23	2.35	0.24	0.47	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	37.92	2.34	1.17	0.29	0.00	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	34.80	4.01	0.00	0.42	0.00	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	27.45	1.75	0.35	0.00	0.35	2.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	37.34	4.82	0.20	0.00	0.40	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	46.53	2.56	0.23	0.47	0.23	2.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	28.07	2.16	0.24	0.00	0.48	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	47.69	2.68	0.30	0.30	0.30	2.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	29.92	3.59	0.72	0.00	0.48	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	29.32	2.63	0.81	0.00	0.20	2.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	36.89	4.10	0.00	0.82	0.61	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	38.69	2.00	0.89	1.11	0.44	2.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	727.59	27.98	13.99	13.99	0.00	27.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	26.61	2.84	0.35	0.00	0.35	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	21.21	2.98	0.00	0.00	0.00	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	95.64	10.91	0.84	3.36	0.00	4.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	53.73	3.21	0.92	0.46	0.00	4.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	18.80	0.97	0.00	0.65	0.00	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	20.55	2.89	0.96	0.00	0.00	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	40.23	2.83	0.31	0.00	0.31	3.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	12.69	0.71	0.00	0.00	0.00	2.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	26.92	3.93	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	39.01	2.39	0.00	0.00	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	29.90	1.70	0.68	0.00	0.00	2.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	22.74	0.65	0.32	0.65	0.00	2.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	13.49	1.06	0.00	0.35	0.00	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	468.75	32.33	0.00	0.00	0.00	64.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	347.49	47.38	15.79	15.79	0.00	23.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	12.68	0.49	0.98	0.00	0.00	2.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	11.90	0.99	0.00	0.00	0.00	2.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	12.67	1.88	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	27.49	1.32	0.33	0.33	0.33	1.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	19.49	3.40	0.00	0.00	0.00	1.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	27.52	2.75	0.00	0.00	0.00	2.45
Adipocyte - breast, donor1	11376-118A8	19.48	0.79	0.16	0.16	0.00	1.11
Adipocyte - breast, donor2	11327-117E4	16.84	0.48	0.00	0.16	0.00	0.32
Adipocyte - omental, donor1	11473-119C6	14.12	1.27	0.00	0.25	0.00	1.40
Adipocyte - omental, donor2	11474-119C7	14.20	0.00	0.75	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	10.72	0.67	0.00	0.00	0.00	0.67
Adipocyte - perirenal, donor1	11476-119C9	15.31	0.64	0.00	0.00	0.00	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	11.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	9.48	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	11.12	0.52	0.00	0.17	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	18.58	1.96	0.00	0.39	0.00	1.76
Adipocyte differentiation, day04, donor2	13022-139D7	20.85	0.51	0.00	0.00	0.00	2.06
Adipocyte differentiation, day04, donor3	13025-139E1	22.86	1.39	0.56	0.00	0.00	1.95
Adipocyte differentiation, day04, donor4	13028-139E4	19.40	0.59	0.59	0.00	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	6.76	0.40	0.24	0.00	0.00	0.64
Adipocyte differentiation, day08, donor2	13023-139D8	7.42	0.65	0.00	0.00	0.00	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	9.60	1.07	0.53	0.00	0.00	1.60
Adipocyte differentiation, day08, donor4	13029-139E5	6.12	0.56	0.00	0.00	0.00	2.23
Adipocyte differentiation, day12, donor1	13021-139D6	7.49	0.42	0.00	0.00	0.00	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	4.02	0.50	0.00	0.00	0.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	7.20	0.98	0.00	0.00	0.00	1.31
Adipocyte differentiation, day12, donor4	13030-139E6	3.35	0.30	0.00	0.00	0.00	0.91
Alveolar Epithelial Cells, donor1	11510-119G7	67.18	1.77	0.66	0.00	0.00	2.43
Alveolar Epithelial Cells, donor2	11590-120G6	12.19	0.00	0.00	0.36	0.00	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	5.99	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	55.77	1.26	2.70	0.54	0.54	1.44
Amniotic Epithelial Cells, donor2	11613-122A2	25.10	0.00	1.67	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	18.70	1.03	0.62	0.00	0.21	1.03
Anulus Pulposus Cell, donor1	11248-116E6	81.81	4.00	0.34	1.14	0.46	2.17
Anulus Pulposus Cell, donor2	11463-119B5	55.10	0.98	0.24	0.49	0.00	1.71
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	15.73	0.45	0.00	0.00	0.00	1.35
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	15.19	0.00	0.00	0.43	0.00	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	14.98	0.00	0.00	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	15.54	1.20	0.00	0.00	0.00	1.20
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	18.97	2.53	0.00	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	7.26	1.98	0.00	0.00	0.00	1.98
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	13.97	1.30	0.65	1.30	0.00	2.60
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	14.56	1.94	0.49	0.49	0.00	2.91
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	9.50	1.19	0.00	0.00	0.00	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	17.70	0.00	0.00	0.75	0.00	1.51
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	22.50	1.45	0.73	0.73	0.00	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	5.02	3.76	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	16.97	0.82	0.16	0.16	0.00	1.81
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	6.82	2.73	0.00	1.36	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	9.05	0.75	0.15	0.00	0.00	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	21.43	2.14	0.54	0.00	0.00	2.14
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	16.63	1.32	0.00	0.00	0.00	1.89
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	16.04	2.14	0.00	1.07	0.00	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	13.66	0.00	0.00	0.00	0.00	3.90
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	18.08	1.66	0.00	0.17	0.00	1.49
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	15.61	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	14.16	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	12.01	0.51	0.17	0.00	0.00	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	0.00	0.00	0.00	0.00	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	17.48	0.49	0.00	0.00	0.49	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	15.18	1.52	0.38	0.00	0.00	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	4.85	3.63	1.21	0.00	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	18.24	0.57	0.00	0.00	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	10.90	1.50	0.00	0.00	0.00	1.92
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	8.26	1.81	0.52	0.26	0.00	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	10.32	0.94	0.47	0.00	0.00	1.88
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	11.58	1.61	0.00	0.32	0.00	1.61
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	7.13	0.71	0.00	0.00	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	13.45	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	10.84	0.30	0.00	0.30	0.30	1.20
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	14.26	0.00	0.00	0.00	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	17.80	1.02	0.51	0.51	0.00	2.03
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	16.30	0.76	0.00	0.76	0.00	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	9.53	1.27	0.00	0.64	0.00	1.91
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	17.26	0.00	0.43	0.00	0.00	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	11.22	0.85	0.00	0.00	0.00	1.91
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	6.96	1.45	0.00	0.29	0.00	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	12.28	0.00	0.00	0.00	0.00	2.83
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	15.09	1.02	0.00	0.00	0.00	1.02
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	13.90	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	14.79	2.11	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	11.79	0.64	0.00	0.00	0.00	0.64
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	12.03	1.20	0.00	0.00	0.00	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	22.60	0.00	0.00	0.00	0.00	2.19
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	12.64	1.38	0.23	0.23	0.00	1.38
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	12.75	0.00	0.00	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	8.39	0.51	0.00	0.00	0.00	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	11.97	0.62	0.00	0.41	0.00	1.03
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	11.32	0.61	0.00	0.31	0.31	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	17.69	0.96	0.00	0.48	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	9.53	0.89	0.00	0.44	0.00	1.11
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	9.15	0.00	0.00	0.00	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	12.19	1.11	0.00	0.00	0.00	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	14.03	1.85	0.00	0.26	0.00	1.59
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	7.27	0.73	0.36	0.73	0.00	0.73
Astrocyte - cerebellum, donor1	11500-119F6	165.07	3.19	3.93	0.74	1.47	6.39
Astrocyte - cerebellum, donor2	11580-120F5	59.22	2.74	3.08	0.51	0.34	1.88
Astrocyte - cerebellum, donor3	11661-122F5	29.99	1.26	0.84	0.21	0.21	0.84
Astrocyte - cerebral cortex, donor1	11235-116D2	385.88	29.28	3.83	3.49	2.79	15.69
Astrocyte - cerebral cortex, donor2	11316-117D2	364.15	35.91	5.01	10.35	1.94	12.62
Astrocyte - cerebral cortex, donor3	11392-118C6	374.69	37.14	3.73	3.73	1.34	15.51
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	430.87	105.63	8.37	7.68	1.61	68.70
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	467.55	101.85	9.90	5.64	1.88	66.65
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	458.37	104.47	8.65	6.49	0.68	76.70
Basophils, donor1	12241-129G9	173.13	2.88	2.09	0.26	0.52	2.09
Basophils, donor2	12242-129H1	221.17	7.58	2.16	1.08	0.36	8.30
Basophils, donor3	12243-129H2	103.19	7.35	0.29	0.59	0.29	2.79
Bronchial Epithelial Cell, donor1	11511-119G8	4.31	0.22	0.22	0.22	0.00	0.65
Bronchial Epithelial Cell, donor2	11591-120G7	4.57	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	0.00	0.00	0.00	0.00	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	43.31	0.63	0.00	0.63	0.00	3.14
Bronchial Epithelial Cell, donor5	11457-119A8	17.26	0.42	0.21	0.00	0.00	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	18.65	0.69	0.00	0.00	0.00	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	25.91	1.98	0.18	0.90	0.00	2.34
Burkitt's lymphoma cell line:DAUDI	10422-106C8	1018.08	137.68	9.17	5.67	5.26	82.96
Burkitt's lymphoma cell line:RAJI	10476-106I8	829.14	72.20	2.79	5.12	0.23	34.24
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	652.66	42.21	4.80	2.88	1.28	15.67
CD133+ stem cells - cord blood derived, pool1	12223-129E9	258.55	20.68	0.00	10.34	0.00	20.68
CD14+ Monocytes, donor1	11224-116B9	64.25	1.69	0.00	0.00	0.56	2.25
CD14+ Monocytes, donor2	11305-117B9	82.04	2.41	0.56	2.23	0.93	2.04
CD14+ Monocytes, donor3	11381-118B4	64.10	3.29	0.22	1.54	0.00	2.20
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	66.23	3.68	0.57	0.00	0.00	3.96
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	64.06	3.03	0.00	0.00	0.00	5.69
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	73.97	4.27	0.33	0.33	0.33	4.27
CD14+ monocytes - mock treated, donor1	11863-125A9	178.81	4.77	0.72	3.32	0.29	1.16
CD14+ monocytes - mock treated, donor2	11873-125C1	92.64	2.41	0.30	0.00	0.00	0.91
CD14+ monocytes - mock treated, donor3	11883-125D2	115.37	3.08	0.00	0.71	0.24	1.18
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	69.30	1.51	0.17	0.50	0.17	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	52.72	1.10	0.00	1.93	0.00	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	61.98	0.74	0.00	0.00	0.00	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	61.09	0.59	0.00	0.39	0.20	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	62.14	0.71	0.00	0.53	0.00	1.25
CD14+ monocytes - treated with BCG, donor3	11880-125C8	86.62	1.52	0.00	0.44	0.00	1.09
CD14+ monocytes - treated with Candida, donor1	11868-125B5	98.57	1.87	0.00	0.23	0.23	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	107.19	2.11	0.00	1.06	0.53	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	108.72	1.11	1.11	0.00	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	86.72	2.68	0.15	1.19	0.15	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	56.87	1.60	0.60	0.40	0.00	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	80.57	1.04	0.00	0.21	0.00	0.83
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	81.22	1.83	0.23	1.14	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	68.09	1.13	0.00	0.45	0.00	1.13
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	64.60	2.62	0.00	0.87	0.00	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	100.06	1.61	0.00	0.27	0.00	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	99.97	1.74	0.70	0.17	0.00	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	86.27	2.10	0.42	0.00	0.00	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	62.28	1.29	0.00	0.37	0.00	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	36.64	1.76	0.00	0.35	0.00	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	49.14	0.44	0.00	0.00	0.00	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	63.82	1.22	0.00	0.17	0.00	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	59.10	1.12	0.00	1.12	0.00	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	91.18	2.59	0.22	0.43	0.00	0.86
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	58.56	4.09	0.00	1.23	0.00	1.23
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	66.53	2.55	0.00	0.23	0.23	1.39
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	76.09	1.39	0.00	0.70	0.00	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	138.41	3.05	0.00	0.87	0.00	5.01
CD14+CD16+ Monocytes, donor2	11801-124D1	123.12	3.00	0.00	0.46	0.00	4.16
CD14+CD16+ Monocytes, donor3	11912-125G4	132.79	3.90	0.87	0.43	0.00	2.60
CD14+CD16- Monocytes, donor1	11788-124B6	306.93	9.65	1.56	2.18	0.47	2.02
CD14+CD16- Monocytes, donor2	11799-124C8	290.08	5.24	0.70	2.10	0.87	1.57
CD14+CD16- Monocytes, donor3	11910-125G2	437.69	8.92	2.68	2.90	0.45	3.79
CD14-CD16+ Monocytes, donor1	11790-124B8	137.03	3.83	0.77	0.26	0.26	5.36
CD14-CD16+ Monocytes, donor2	11800-124C9	131.30	2.63	0.22	1.54	0.44	5.71
CD14-CD16+ Monocytes, donor3	11911-125G3	136.22	3.16	0.21	0.84	0.63	4.84
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	138.20	12.19	2.03	0.00	0.00	16.26
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	127.46	18.98	2.71	0.00	0.68	18.31
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	112.88	15.53	0.00	1.04	1.04	18.64
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	141.26	24.52	1.07	0.00	0.00	16.52
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	130.26	16.62	0.54	0.00	0.00	25.20
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	122.14	18.95	1.40	0.70	1.40	26.67
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	150.60	16.47	0.00	0.00	0.78	22.75
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	134.47	17.14	0.00	0.00	0.00	23.73
CD19+ B Cells, donor1	11544-120B5	103.56	9.86	0.00	0.00	0.00	13.15
CD19+ B Cells, donor2	11624-122B4	109.54	8.71	0.73	1.45	0.00	6.53
CD19+ B Cells, donor3	11705-123B4	97.94	7.07	0.00	1.01	0.00	12.62
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	6751.39	181.83	100.21	35.96	24.65	51.72
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	4478.69	128.24	62.32	23.17	17.58	31.56
CD34+ Progenitors, donor1	11545-120B6	104.42	3.01	1.00	0.00	0.00	7.03
CD34+ Progenitors, donor2	11625-122B5	136.52	2.25	1.12	0.56	0.00	4.49
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	841.69	32.31	7.14	2.63	4.51	15.78
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	1073.08	39.46	7.44	2.48	4.28	17.59
CD4+ T Cells, donor1	11225-116C1	170.67	8.57	2.50	0.71	1.07	12.85
CD4+ T Cells, donor2	11306-117C1	178.81	10.41	0.61	4.29	1.84	13.47
CD4+ T Cells, donor3	11382-118B5	154.94	13.11	2.13	2.13	0.30	11.89
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	157.23	15.57	5.10	1.02	0.77	18.63
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	133.41	23.36	5.39	0.67	1.35	21.79
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	100.90	14.95	5.75	1.72	0.00	22.13
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	540.46	20.86	2.37	2.37	0.47	30.34
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	560.45	25.28	0.70	4.92	0.00	42.14
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	290.07	13.18	3.30	6.59	0.00	29.67
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	390.91	22.83	8.09	1.45	1.73	18.93
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	316.22	30.50	10.00	5.42	2.37	16.27
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	255.51	24.34	11.12	6.29	1.77	17.89
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	466.23	23.76	3.14	5.38	1.79	29.59
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	451.76	27.25	3.14	4.19	1.40	31.44
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	464.18	23.76	3.08	1.76	0.88	30.36
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	618.13	25.30	10.96	3.37	1.26	20.24
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	461.04	44.88	14.75	7.27	2.29	16.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	408.64	27.73	13.70	9.36	1.34	13.03
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	222.71	14.68	0.54	2.45	1.63	23.39
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	284.05	19.83	1.07	4.29	0.00	34.84
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	222.36	12.55	0.00	1.79	0.00	41.24
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	659.01	46.54	20.95	4.64	3.52	24.48
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	447.10	44.84	13.00	1.95	3.90	15.60
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	486.50	41.19	13.03	2.52	3.57	17.65
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	345.33	19.72	9.10	4.55	0.51	26.80
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	460.11	26.86	7.80	2.60	1.30	26.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	394.41	25.28	5.67	2.18	2.18	35.74
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	228.13	39.09	3.96	0.99	2.47	30.19
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	176.33	22.16	7.39	0.92	1.85	26.77
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	242.87	25.12	5.58	0.00	1.40	32.10
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	220.44	5.54	4.15	0.28	1.94	29.63
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	198.77	11.53	4.66	0.74	1.72	36.81
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	223.30	24.64	4.62	0.00	1.54	30.80
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	263.22	30.44	4.30	0.36	0.72	30.44
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	258.99	23.54	9.69	1.38	2.77	31.85
CD8+ T Cells, donor1	11226-116C2	191.20	9.82	0.98	0.98	0.98	13.42
CD8+ T Cells, donor2	11307-117C2	191.47	5.26	0.38	5.26	0.00	6.01
CD8+ T Cells, donor3	11383-118B6	153.01	9.34	1.77	1.77	0.76	7.83
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	87.63	3.90	0.23	0.69	0.46	11.47
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	77.88	4.79	0.24	0.72	0.00	9.59
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	87.55	5.75	0.55	1.09	0.00	12.31
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	102.97	8.11	0.30	0.60	0.30	13.81
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	72.47	5.28	0.00	0.96	0.00	9.36
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	83.68	5.23	0.68	0.45	0.00	11.37
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	150.80	7.39	1.52	1.52	0.22	13.47
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	154.24	6.84	0.79	2.37	0.00	11.32
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	154.78	7.50	0.23	1.41	0.00	17.35
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	246.03	9.36	0.60	2.11	0.00	14.79
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	219.04	12.78	0.29	1.16	0.00	12.20
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	251.78	8.79	0.53	1.87	0.00	16.25
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	161.97	5.69	0.00	0.00	0.00	7.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	199.02	4.55	0.91	0.00	0.00	10.02
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	125.31	6.71	0.75	0.75	0.00	6.71
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	80.67	3.24	0.00	0.72	0.00	15.13
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	69.92	3.74	0.00	0.86	0.00	10.65
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	71.65	3.30	0.24	0.47	0.00	9.19
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	216.76	9.82	0.95	2.22	0.00	20.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	172.24	7.69	0.31	0.62	0.00	23.68
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	159.01	8.01	0.32	2.56	0.00	16.35
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	231.01	6.88	0.76	1.53	0.00	18.74
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	231.73	9.46	0.79	1.58	0.00	13.01
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	215.58	3.78	0.00	0.76	0.00	15.13
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	262.57	8.03	0.80	2.41	0.80	18.47
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	240.60	8.39	1.40	1.40	0.00	18.19
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	333.58	5.01	0.00	3.01	0.00	8.01
Cardiac Myocyte, donor1	11525-119I4	32.90	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	60.77	4.94	0.49	0.99	0.00	1.48
Cardiac Myocyte, donor3	11686-122I3	83.77	4.10	0.11	0.32	0.00	1.89
Chondrocyte - de diff, donor1	11261-116G1	179.23	3.47	0.00	0.00	0.35	3.47
Chondrocyte - de diff, donor2	11338-117F6	22.39	0.00	0.00	0.00	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	67.13	2.16	0.46	1.02	0.00	0.80
Chondrocyte - re diff, donor2	11339-117F7	151.30	3.58	1.79	0.00	0.90	5.37
Chondrocyte - re diff, donor3	11411-118E7	43.27	2.43	0.00	0.81	0.00	2.02
Ciliary Epithelial Cells, donor1	11242-116D9	521.58	39.13	3.67	2.75	1.26	10.33
Ciliary Epithelial Cells, donor2	11323-117D9	175.72	14.11	0.86	5.34	0.86	3.21
Ciliary Epithelial Cells, donor3	11399-118D4	240.89	15.93	0.88	2.30	0.44	4.78
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	68.96	5.96	0.55	0.64	0.18	10.73
Corneal Epithelial Cells, donor1	11526-119I5	10.54	0.22	0.22	0.00	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	44.37	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	34.00	3.07	0.77	0.77	0.00	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	8.42	1.49	0.00	0.00	0.17	4.95
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	13.88	1.26	0.32	0.00	0.00	4.10
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	13.80	6.90	3.45	0.00	0.00	6.90
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	7.99	1.84	0.00	0.32	0.00	2.05
Dendritic Cells - plasmacytoid, donor1	11228-116C4	48.51	7.17	0.34	0.00	0.68	15.03
Dendritic Cells - plasmacytoid, donor2	11309-117C4	61.37	9.14	3.92	0.00	0.65	15.67
Dendritic Cells - plasmacytoid, donor3	11385-118B8	72.11	3.39	0.48	0.97	0.48	23.71
Endothelial Cells - Aortic, donor0	11207-116A1	72.21	4.67	1.00	0.17	0.50	2.50
Endothelial Cells - Aortic, donor1	11263-116G3	26.99	1.76	0.59	0.00	0.59	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	72.96	3.11	1.41	0.28	0.28	3.96
Endothelial Cells - Aortic, donor3	11412-118E8	33.81	0.39	0.00	0.00	0.00	1.97
Endothelial Cells - Artery, donor1	11264-116G4	30.54	1.75	0.29	0.00	0.00	1.75
Endothelial Cells - Artery, donor2	11341-117F9	88.94	4.94	0.24	1.41	0.00	3.06
Endothelial Cells - Artery, donor3	11413-118E9	45.93	3.51	0.18	0.18	0.00	2.10
Endothelial Cells - Lymphatic, donor1	11236-116D3	29.48	2.44	0.66	0.00	0.44	2.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	36.82	2.43	1.22	0.00	0.30	2.13
Endothelial Cells - Lymphatic, donor3	11393-118C7	42.00	3.95	0.85	0.00	0.28	2.26
Endothelial Cells - Microvascular, donor1	11265-116G5	56.16	0.59	1.19	0.00	0.30	1.78
Endothelial Cells - Microvascular, donor2	11342-117G1	20.31	0.00	0.52	0.52	0.52	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	30.20	2.41	0.85	0.57	0.57	1.28
Endothelial Cells - Thoracic, donor1	11266-116G6	152.85	1.60	2.00	0.00	0.40	5.20
Endothelial Cells - Thoracic, donor2	11343-117G2	18.34	0.52	0.00	0.00	0.00	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	400.45	33.42	3.98	3.73	2.11	10.81
Endothelial Cells - Umbilical vein, donor2	11324-117E1	272.66	21.29	1.74	3.26	1.96	8.26
Endothelial Cells - Umbilical vein, donor3	11400-118D5	316.31	26.87	3.18	1.83	2.20	10.26
Endothelial Cells - Vein, donor1	11267-116G7	32.99	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	20.26	0.70	2.79	0.00	0.70	2.79
Endothelial Cells - Vein, donor3	11416-118F3	73.64	4.08	1.10	1.10	0.31	2.20
Eosinophils, donor1	12244-129H3	564.14	0.00	0.00	0.00	0.00	15.25
Eosinophils, donor2	12245-129H4	234.34	4.95	0.00	0.00	0.00	1.65
Eosinophils, donor3	12246-129H5	278.21	10.70	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	13.44	0.49	0.49	0.24	0.00	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	27.09	0.82	0.00	0.41	0.00	1.23
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	3.72	0.44	0.00	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	58.50	2.06	0.43	0.43	0.11	1.73
Fibroblast - Aortic Adventitial, donor1	11245-116E3	123.58	7.88	1.21	0.73	0.49	2.91
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	15.83	0.68	0.00	0.27	0.00	1.23
Fibroblast - Aortic Adventitial, donor2	11326-117E3	14.87	0.63	0.00	0.00	0.00	0.63
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	75.09	1.05	0.26	0.79	0.26	2.63
Fibroblast - Aortic Adventitial, donor3	11401-118D6	174.07	13.29	0.00	2.66	1.00	3.32
Fibroblast - Cardiac, donor1	11268-116G8	30.39	1.81	0.45	0.45	0.00	0.91
Fibroblast - Cardiac, donor2	11345-117G4	16.67	0.00	0.76	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	18.30	0.95	0.16	0.16	0.16	0.63
Fibroblast - Cardiac, donor4	11452-119A3	76.99	6.06	0.30	0.30	0.00	2.73
Fibroblast - Cardiac, donor5	11456-119A7	84.39	2.41	0.13	1.65	0.25	1.90
Fibroblast - Cardiac, donor6	11460-119B2	119.46	3.18	1.67	0.91	0.30	3.34
Fibroblast - Choroid Plexus, donor1	11492-119E7	31.35	1.07	1.21	0.00	0.00	1.07
Fibroblast - Choroid Plexus, donor2	11572-120E6	11.22	0.43	0.00	0.43	0.00	1.29
Fibroblast - Choroid Plexus, donor3	11653-122E6	90.82	13.18	0.00	5.86	0.00	10.25
Fibroblast - Conjunctival, donor1	11531-120A1	99.17	2.77	1.61	0.46	0.23	1.85
Fibroblast - Conjunctival, donor3	11692-122I9	40.03	2.37	0.85	0.00	0.51	2.54
Fibroblast - Dermal, donor1	11269-116G9	30.76	0.94	0.23	0.00	0.00	1.64
Fibroblast - Dermal, donor2	11346-117G5	48.11	1.42	0.00	0.00	0.00	2.83
Fibroblast - Dermal, donor3	11418-118F5	44.24	1.93	0.36	0.97	0.12	1.33
Fibroblast - Dermal, donor4	11450-119A1	264.07	8.37	2.15	3.05	0.57	12.10
Fibroblast - Dermal, donor5	11454-119A5	222.43	6.80	3.31	1.92	1.05	10.29
Fibroblast - Dermal, donor6	11458-119A9	261.34	9.58	3.57	1.30	0.32	17.38
Fibroblast - Gingival, donor1	11237-116D4	54.97	3.96	0.62	0.00	0.00	2.92
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	76.24	5.50	1.05	1.05	0.52	4.19
Fibroblast - Gingival, donor2	11318-117D4	199.26	23.46	3.43	5.67	0.79	7.78
Fibroblast - Gingival, donor3	11394-118C8	81.51	2.51	0.48	0.39	0.19	1.45
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	62.33	2.08	1.04	0.00	0.00	3.12
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	37.36	2.82	0.35	1.06	0.18	1.76
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	225.27	12.16	1.71	1.56	0.62	3.59
Fibroblast - Gingival, donor6 (control)	11922-125H5	164.17	8.38	3.25	1.49	0.68	4.73
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	38.11	3.18	1.06	0.00	0.35	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	131.33	8.34	2.49	0.88	0.44	3.22
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	148.63	12.82	0.82	0.68	0.27	4.36
Fibroblast - Gingival, donor8 (control)	11926-125H9	149.95	9.87	2.08	0.99	0.55	3.73
Fibroblast - Gingival, donor9 (control)	11927-125I1	53.12	4.26	0.29	0.59	0.73	2.35
Fibroblast - Lung, donor1	11270-116H1	17.67	4.08	2.72	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	237.25	7.46	2.98	0.00	0.00	8.95
Fibroblast - Lung, donor3	11419-118F6	146.46	11.40	2.11	2.74	0.42	5.06
Fibroblast - Lymphatic, donor1	11506-119G3	57.48	0.00	1.67	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	25.18	0.00	1.40	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	7.56	0.28	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	99.06	4.47	0.81	0.00	0.41	4.47
Fibroblast - Mammary, donor2	11620-122A9	11.98	0.00	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	285.72	23.47	4.85	1.94	1.36	12.61
Fibroblast - Periodontal Ligament, donor2	11319-117D5	398.47	32.91	4.85	5.61	1.21	12.89
Fibroblast - Periodontal Ligament, donor3	11395-118C9	146.26	9.18	1.53	0.00	0.31	5.81
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	130.90	5.34	1.53	0.76	0.38	4.58
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	79.11	7.02	1.08	1.89	0.54	2.43
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	45.93	2.32	0.70	0.35	0.00	1.62
Fibroblast - Pulmonary Artery, donor1	11250-116E8	121.59	8.18	1.88	0.77	0.66	3.09
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	102.20	3.86	2.64	0.20	0.20	1.63
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	41.43	0.00	2.67	0.00	0.00	3.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	50.21	2.77	0.00	0.00	0.00	3.16
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	169.87	5.56	0.79	0.60	0.00	4.56
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	65.36	1.78	0.00	0.18	0.00	1.95
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	47.30	1.97	0.39	0.39	0.00	1.97
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	98.38	3.31	0.00	0.30	0.90	5.42
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	129.11	2.91	0.54	0.54	0.11	3.89
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	68.84	1.52	0.00	0.51	0.00	2.53
Fibroblast - skin normal, donor1	11553-120C5	64.32	1.97	0.16	0.66	0.16	1.97
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	128.53	9.22	0.80	0.20	1.00	4.41
Fibroblast - skin normal, donor2	11561-120D4	199.72	4.32	1.51	0.40	0.30	5.12
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	117.57	4.53	0.00	0.30	0.60	4.84
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	65.37	2.98	0.33	0.33	0.17	2.98
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	41.20	1.37	0.34	0.17	0.68	3.59
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	71.60	2.96	0.00	0.66	0.33	3.61
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	235.09	4.15	1.81	0.43	0.11	4.15
Fibroblast - skin walker warburg, donor1	11554-120C6	154.34	3.88	1.18	1.69	0.00	2.53
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	67.75	2.82	0.16	0.94	0.31	1.25
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	2083.02	44.32	0.00	0.00	22.16	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	33.99	0.00	1.74	0.87	0.00	4.36
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	15.95	1.91	0.35	0.00	0.00	0.87
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	30.97	3.12	0.00	0.00	0.00	2.34
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	35.77	1.79	0.00	0.00	0.00	1.02
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	185.26	16.08	0.00	1.53	0.00	12.25
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	206.10	15.31	0.64	4.47	0.00	15.31
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	320.07	37.37	0.29	4.28	0.29	35.66
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	429.35	28.95	1.10	7.45	0.83	21.78
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	352.08	23.06	1.14	6.39	0.46	12.10
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	260.54	27.94	0.99	4.76	0.00	25.56
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	395.97	29.61	1.32	8.19	0.26	19.83
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	394.64	17.61	1.30	3.26	0.65	11.09
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	283.47	20.78	0.44	6.63	0.00	26.98
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	346.66	29.54	0.57	2.40	0.14	35.47
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	267.34	18.10	0.74	3.32	0.00	20.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	222.96	22.30	0.81	3.49	0.27	20.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	229.70	16.85	1.12	1.86	0.37	23.17
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	249.03	23.39	1.11	3.88	0.14	29.35
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	157.97	23.18	0.00	2.64	0.41	18.09
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	118.65	14.38	1.37	1.14	0.68	11.64
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	134.78	10.46	0.37	2.87	0.25	15.94
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	110.38	18.14	0.87	1.97	0.00	17.27
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	150.10	13.30	1.48	0.89	0.30	10.34
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	235.10	16.05	0.95	3.18	1.11	13.83
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	159.52	15.86	1.12	1.56	0.00	10.72
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	178.85	16.53	1.01	3.63	0.20	8.07
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	261.42	14.42	0.68	5.26	0.34	15.10
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	214.14	15.78	0.89	0.71	0.18	12.68
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	156.08	12.69	0.83	0.31	0.21	9.78
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	134.74	8.71	0.85	0.34	0.17	10.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	180.70	11.62	0.66	1.55	0.22	9.85
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	194.68	13.23	0.75	0.67	0.17	10.32
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	184.99	13.48	0.41	0.41	0.41	10.82
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	138.64	17.12	0.62	1.24	0.41	8.46
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	176.86	9.80	1.04	2.31	0.12	12.11
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	129.41	8.67	0.50	1.17	0.00	6.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	84.87	9.92	1.10	0.22	0.22	6.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	122.62	7.26	0.49	1.60	0.12	7.87
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	134.37	12.32	1.13	1.78	0.16	6.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	76.33	9.30	0.32	1.28	0.00	6.74
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	107.93	6.25	0.38	2.46	0.38	6.35
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	83.68	6.96	0.47	0.16	0.32	4.43
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	86.66	6.08	0.61	1.82	0.30	7.60
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	103.18	4.81	0.42	1.57	0.21	6.48
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	58.40	5.05	0.66	0.88	0.00	3.51
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	70.98	8.98	1.12	1.40	0.28	6.73
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	55.83	2.87	0.65	0.19	0.00	2.96
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	51.07	2.67	0.53	1.87	0.00	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	53.70	4.59	0.46	1.07	0.46	2.60
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	74.74	3.11	0.26	1.42	0.26	2.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	39.58	2.98	0.00	0.54	0.00	3.25
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	43.88	3.69	0.18	0.55	0.18	1.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	50.44	4.17	0.00	0.22	0.44	2.63
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	50.58	5.95	0.99	0.00	0.00	3.97
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	65.30	4.75	0.53	0.66	0.00	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	47.41	4.24	0.40	0.81	0.20	2.42
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	62.02	3.30	1.27	0.00	0.51	3.81
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	354.92	12.94	1.00	0.80	0.60	48.57
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	310.77	30.04	0.46	4.93	0.31	30.66
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	424.51	33.76	1.23	3.48	0.41	49.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	295.72	27.22	0.63	3.13	0.00	17.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	303.46	31.36	0.85	3.11	0.00	18.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	386.03	29.52	0.92	9.69	0.00	27.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	400.92	29.70	0.00	12.37	0.00	22.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	458.76	33.65	0.39	7.74	0.00	20.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	239.07	30.48	3.21	1.60	1.60	9.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	361.68	24.34	0.00	12.17	1.74	17.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	443.63	39.38	0.65	9.44	0.33	14.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	420.04	39.12	1.24	6.59	0.00	26.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	363.22	46.65	0.00	23.33	0.00	13.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	409.68	37.75	1.96	8.39	0.28	13.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	423.92	34.32	1.63	8.82	0.00	17.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	333.02	32.71	0.84	14.26	0.84	10.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	452.62	38.17	3.18	8.27	0.32	18.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	424.58	36.68	1.02	8.49	0.00	12.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	451.04	25.06	4.18	8.35	0.00	8.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	549.22	43.53	1.72	7.45	0.57	21.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	311.97	24.27	1.78	10.66	0.89	14.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	367.63	33.88	0.00	15.25	0.00	11.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	516.52	29.41	1.66	14.91	0.41	11.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	481.20	33.83	0.92	9.44	0.23	13.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	326.65	15.81	0.00	0.00	0.00	10.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	385.95	24.22	2.31	10.38	0.38	15.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	371.93	27.06	0.33	5.54	0.00	16.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	358.50	24.08	0.67	2.01	0.67	8.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	477.73	37.76	2.70	12.71	0.39	25.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	343.02	22.25	2.74	4.45	0.68	10.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	245.99	19.88	2.48	14.91	0.00	9.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	395.88	33.03	0.47	10.38	0.00	16.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	320.46	19.31	4.22	13.88	0.60	20.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	335.73	30.01	2.03	5.09	0.51	21.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	390.06	37.09	0.80	7.18	0.80	16.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	372.98	27.13	0.49	9.37	0.00	15.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	286.85	27.15	1.18	9.44	1.18	15.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	356.49	30.34	2.92	5.83	0.00	14.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	288.35	21.51	0.88	6.58	0.44	17.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	258.55	16.95	0.00	9.32	0.00	16.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	226.23	14.33	0.60	7.16	0.60	6.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	319.29	18.44	1.46	8.25	0.00	7.28
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	20.54	1.14	1.14	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	25.78	1.66	0.00	0.00	0.00	1.25
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	28.11	4.50	1.12	0.00	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	76.12	8.25	0.63	1.27	0.00	2.22
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	38.01	1.25	0.42	0.84	0.00	1.25
Hep-2 cells mock treated, biol_rep1	11898-125E8	129.15	5.69	0.93	1.28	0.35	1.62
Hep-2 cells mock treated, biol_rep2	11899-125E9	137.24	5.06	0.68	1.86	0.17	1.18
Hep-2 cells mock treated, biol_rep3	11900-125F1	122.17	6.60	1.37	1.14	0.00	1.82
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	113.90	5.47	1.42	1.20	0.11	3.28
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	113.47	3.44	0.43	1.72	0.43	1.93
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	102.04	4.52	1.08	1.72	0.00	2.58
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	91.41	3.61	1.00	2.74	0.25	1.49
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	84.40	3.09	1.89	0.86	0.00	2.74
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	96.75	2.24	0.96	1.28	0.32	1.28
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	66.60	1.12	4.48	1.12	0.00	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	9.52	0.87	0.43	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	31.73	7.93	0.00	2.64	0.00	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	27.87	0.35	0.71	0.35	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	7.99	0.00	0.73	0.00	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	129.38	8.39	0.35	2.80	0.17	3.50
Hepatocyte, donor1	11523-119I2	9.68	1.21	0.00	0.00	0.00	1.21
Hepatocyte, donor2	11603-120I1	12.93	0.00	0.00	0.00	0.00	1.08
Hepatocyte, donor3	11684-122I1	25.77	2.45	0.00	0.00	0.00	3.68
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	956.84	65.92	13.05	18.28	2.61	23.50
Intestinal epithelial cells (polarized), donor1	11246-116E4	244.52	9.79	1.05	2.10	0.17	3.32
Iris Pigment Epithelial Cells, donor1	11530-119I9	78.35	10.29	0.82	0.55	0.00	4.53
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	82.78	3.18	3.18	0.00	0.00	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	60.08	0.00	0.00	0.00	0.00	13.35
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	27.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	106.60	1.38	0.00	0.00	0.00	2.77
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	82.59	0.00	2.50	0.00	0.00	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	112.77	2.56	0.00	2.56	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	123.41	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	107.21	4.87	1.62	0.00	0.00	4.87
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	70.03	1.67	0.00	0.00	0.00	6.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	72.61	3.63	0.00	0.00	0.00	7.26
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	104.55	6.62	0.00	0.00	0.00	3.97
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	83.15	6.65	0.00	0.00	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	62.86	5.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	116.52	3.78	0.00	0.63	0.00	3.15
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	64.96	1.55	0.00	0.00	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	87.81	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	96.26	3.23	0.00	0.00	0.00	2.58
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	77.28	0.00	0.00	1.61	0.00	6.44
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	119.48	23.90	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	97.79	0.81	0.81	0.81	0.00	4.89
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	56.67	1.68	0.84	0.84	0.00	2.94
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	0.00	0.00	0.00	14.37
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	103.68	4.82	0.80	0.80	0.00	4.02
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	65.55	5.54	0.00	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	90.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	103.38	4.25	0.94	0.00	0.00	3.78
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	55.33	0.91	0.00	0.91	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	103.20	0.00	0.00	0.00	0.00	14.74
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	95.77	1.08	0.00	1.08	0.00	4.30
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	69.88	2.54	2.54	0.00	0.00	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	70.78	1.91	0.64	0.00	0.00	3.19
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	82.02	0.00	0.00	0.00	0.00	3.65
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	94.83	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	84.97	2.86	0.71	0.00	0.00	2.86
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	46.46	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	20.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	114.51	1.85	0.31	2.16	0.00	4.94
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	70.24	1.76	0.00	0.00	0.00	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	97.44	0.00	3.14	0.00	0.00	6.29
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	76.49	1.39	0.70	0.00	0.00	2.09
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	110.65	2.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	100.50	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	91.55	3.49	0.00	0.87	0.87	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	130.49	4.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	73.18	3.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	101.34	2.13	0.00	0.00	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	69.27	0.00	0.00	0.00	0.00	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	68.39	2.85	0.00	0.00	0.00	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	99.41	3.68	0.00	0.00	0.00	2.76
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	105.89	3.03	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	80.71	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	97.28	2.11	0.00	0.00	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	6.69	0.65	0.00	0.00	0.00	0.16
Keratinocyte - epidermal, donor2	11349-117G8	8.20	0.59	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	83.77	7.57	0.76	1.70	0.00	4.73
Keratinocyte - oral, donor1	11251-116E9	104.89	6.81	0.68	1.48	0.11	5.22
Keratocytes, donor1	11527-119I6	79.77	2.41	2.06	0.34	0.34	2.41
Keratocytes, donor2	11607-120I5	41.01	0.00	1.17	0.00	0.00	1.17
Keratocytes, donor3	11688-122I5	38.14	2.96	1.19	0.79	0.00	2.17
Krukenberg tumor cell line:HSKTC	10687-109F3	195.61	13.19	0.00	0.00	0.00	6.59
Lens Epithelial Cells, donor1	11529-119I8	79.83	8.63	0.00	3.24	0.00	5.39
Lens Epithelial Cells, donor2	11609-120I7	188.57	10.38	1.61	0.81	0.46	5.54
Lens Epithelial Cells, donor3	11690-122I7	33.80	2.02	0.20	0.10	0.10	2.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	82.65	4.39	1.07	1.19	0.00	2.02
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	85.12	4.19	0.56	0.84	1.12	1.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	87.36	6.77	0.79	3.46	0.79	2.05
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	63.45	4.30	0.00	1.61	0.00	3.76
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	73.12	3.47	0.63	1.58	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	61.89	3.56	0.65	1.62	0.22	0.97
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	72.64	3.69	1.23	2.05	0.41	2.05
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	44.50	1.77	0.00	0.51	0.00	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	59.82	3.66	0.84	1.69	0.28	0.99
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	92.55	3.96	0.00	1.19	0.40	3.56
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	83.56	4.85	0.00	1.55	0.00	1.74
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	28.14	1.67	0.19	0.56	0.19	1.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	65.50	3.83	0.35	1.39	0.00	3.14
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	73.47	3.82	0.24	0.95	0.24	0.95
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	57.14	3.30	0.41	1.51	0.41	0.82
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	88.38	4.93	0.62	1.23	0.62	1.23
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	40.84	0.94	0.00	1.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	52.15	3.66	0.18	0.73	0.91	1.10
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	66.48	1.65	0.33	1.97	0.99	1.97
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	41.59	2.93	0.29	0.88	0.00	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	29.12	1.24	0.25	0.75	0.00	1.49
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	76.62	4.36	0.48	1.94	0.00	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	88.60	4.04	0.81	1.08	0.54	1.08
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	67.51	2.12	0.45	1.82	0.00	1.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	71.02	0.00	0.00	0.00	0.00	2.59
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	94.02	6.70	0.42	3.35	0.63	1.47
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	58.65	2.26	0.60	1.50	0.15	1.20
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	70.16	4.82	2.75	1.38	0.00	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	83.16	2.82	0.38	0.75	0.38	1.51
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	56.41	3.39	0.32	1.06	0.11	1.17
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	69.29	1.94	0.00	1.94	0.48	2.91
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	68.47	3.31	0.33	0.66	0.66	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	50.42	3.10	0.25	0.99	0.12	1.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	78.48	4.07	0.74	1.48	0.74	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	84.50	5.19	0.49	0.25	0.25	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	45.10	2.61	1.51	0.41	0.55	2.06
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	70.44	5.15	0.00	1.93	0.96	1.93
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	100.12	4.56	0.61	1.52	0.30	3.35
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	105.81	5.18	1.12	2.66	0.70	2.24
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	63.65	6.04	0.71	0.71	0.00	2.84
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	63.02	1.45	0.00	0.48	0.00	1.45
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	33.46	2.33	0.31	1.09	0.47	1.09
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	71.26	3.22	1.07	1.79	0.00	4.30
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	84.61	5.55	1.63	0.65	0.00	1.96
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	36.49	1.65	0.71	0.47	0.00	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	59.65	3.84	0.99	0.12	0.87	1.36
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	47.90	2.31	0.26	0.26	0.26	1.54
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	62.65	3.88	0.60	0.90	0.30	2.39
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	160.89	20.39	0.00	0.00	0.00	4.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	127.34	7.67	0.77	0.00	0.00	4.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	118.01	5.94	0.00	1.48	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	133.71	9.31	2.12	1.69	0.00	3.81
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	104.09	9.85	0.70	2.81	0.00	2.81
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	111.14	9.34	0.93	0.93	0.00	3.74
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	119.54	7.73	2.06	2.58	0.00	2.58
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	110.62	9.52	0.00	1.19	1.19	5.95
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	125.31	7.69	2.49	1.13	0.23	5.65
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	189.04	11.05	1.45	5.23	0.58	4.94
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	223.29	15.31	2.25	4.05	0.45	6.30
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	137.11	9.08	1.76	0.68	0.14	2.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	129.41	8.73	2.57	4.11	0.51	5.65
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	194.07	10.59	1.41	1.41	0.35	3.18
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	164.58	11.33	0.00	5.33	0.00	8.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	116.65	8.15	0.00	2.04	0.51	3.06
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	221.45	12.81	1.60	2.40	0.27	4.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	209.73	15.30	1.70	3.21	0.00	4.72
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	112.90	9.20	0.61	1.84	0.00	6.14
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	163.90	10.60	3.26	0.82	0.82	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	192.00	13.12	1.25	4.16	0.21	5.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	172.64	7.57	2.52	5.04	0.28	4.48
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	140.13	6.18	2.06	3.09	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	174.47	12.77	3.19	7.55	0.00	4.35
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	143.79	7.77	0.60	3.89	0.00	4.48
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	165.42	11.62	0.55	1.11	0.55	4.43
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	109.23	7.42	2.83	3.89	0.35	3.89
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	136.82	9.59	1.11	4.43	0.00	3.69
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	101.31	4.61	1.15	0.00	1.15	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	121.65	8.44	0.38	2.69	0.38	2.30
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	101.34	7.93	0.57	4.53	1.70	3.96
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	120.61	6.56	0.00	0.82	0.00	6.56
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	91.73	5.87	0.90	2.71	0.45	3.62
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	105.57	8.62	0.00	3.59	0.00	2.15
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	131.46	7.47	4.48	0.75	0.00	2.99
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	124.86	7.43	1.11	2.97	0.74	4.83
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	120.18	7.32	0.43	2.15	0.00	3.88
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	101.90	7.71	0.86	2.57	0.00	6.85
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	116.28	9.00	2.00	2.67	0.00	1.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	102.56	1.21	0.60	0.00	0.00	5.43
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	78.92	6.40	1.42	2.13	0.00	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	110.33	7.56	1.72	1.72	0.34	3.78
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	92.86	5.90	3.76	2.68	0.00	2.68
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	92.92	4.04	0.67	1.35	0.00	3.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	111.12	11.85	1.85	3.33	0.37	2.22
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	131.41	8.14	2.33	1.16	2.33	4.65
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	79.33	5.29	2.12	1.06	0.00	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	96.84	8.40	2.00	3.60	0.80	3.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	114.85	8.72	0.73	1.45	0.73	2.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	116.51	11.50	0.77	0.00	0.00	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	123.32	4.44	0.99	4.93	0.00	6.41
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	98.80	3.76	0.94	0.00	1.88	2.82
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	108.61	6.54	2.51	3.02	0.50	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	102.29	8.56	0.45	3.60	0.45	3.15
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	103.27	5.16	3.44	3.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	114.45	8.02	0.45	1.78	0.00	3.56
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	110.66	4.69	0.39	3.13	0.00	4.30
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	102.26	3.30	0.66	1.98	0.66	1.98
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	115.20	9.34	2.08	1.04	0.00	3.11
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	140.02	8.31	2.63	4.81	0.00	4.38
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	122.44	8.39	0.56	3.91	0.56	2.80
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	107.32	3.97	0.44	1.32	0.00	2.21
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	118.03	8.49	2.70	3.09	0.77	4.24
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	110.39	5.06	0.51	3.04	0.51	3.54
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	107.18	7.21	0.96	1.44	0.00	3.84
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	123.24	10.34	1.19	3.18	0.00	4.37
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	99.04	1.22	2.43	3.04	0.00	2.43
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	96.15	2.77	1.38	0.69	0.00	4.84
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	111.72	8.74	0.76	3.04	1.14	3.04
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	96.57	2.58	0.52	1.55	0.52	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	98.56	3.02	1.21	0.60	0.00	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	108.70	9.19	1.27	2.85	1.27	3.17
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	91.69	3.20	0.53	0.00	0.00	2.67
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	101.72	1.15	0.00	0.57	0.00	3.45
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	86.91	6.17	0.51	1.54	0.00	1.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	75.69	5.66	0.00	1.41	0.00	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	81.72	0.57	2.84	0.57	0.57	2.27
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	81.54	4.99	1.25	2.50	0.42	2.50
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	75.96	4.70	1.57	2.35	0.00	3.13
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	72.24	1.67	1.25	0.84	0.42	2.92
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	72.48	5.58	0.00	2.32	0.00	3.72
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	55.53	3.35	0.67	0.00	0.00	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	58.28	0.53	0.00	1.60	0.53	2.14
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	64.66	7.27	0.00	2.42	0.00	5.25
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	38.55	0.00	0.92	0.92	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	50.68	0.89	0.00	2.67	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	53.57	3.42	1.14	0.00	0.00	5.70
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	54.45	3.83	0.00	0.00	0.00	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	68.94	1.09	0.55	0.55	0.55	2.74
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	56.13	3.56	0.89	0.45	0.45	3.12
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	62.65	3.12	1.04	0.26	0.00	1.56
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	65.65	1.99	1.33	1.33	0.00	1.99
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	43.65	4.16	2.08	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	23.48	2.73	0.91	0.00	0.23	6.38
Macrophage - monocyte derived, donor2	11313-117C8	18.53	1.84	0.18	0.00	0.00	0.92
Macrophage - monocyte derived, donor3	11389-118C3	71.05	4.46	1.05	0.52	0.39	2.36
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	21.24	0.53	0.00	0.00	0.00	1.59
Mallassez-derived cells, donor2	11929-125I3	20.12	1.27	0.00	0.16	0.00	1.27
Mallassez-derived cells, donor3	11930-125I4	36.69	1.53	0.14	0.28	0.00	2.36
Mammary Epithelial Cell, donor1	11273-116H4	225.09	9.27	0.30	1.00	0.10	4.68
Mammary Epithelial Cell, donor2	11350-117G9	216.29	4.63	0.00	2.03	0.00	5.50
Mammary Epithelial Cell, donor3	11422-118F9	36.42	5.24	0.00	0.50	0.00	2.00
Mast cell - stimulated, donor1	11487-119E2	522.01	30.51	4.07	3.39	5.42	15.59
Mast cell, donor1	11563-120D6	266.35	9.95	4.97	0.54	2.05	11.25
Mast cell, donor2	11565-120D8	136.70	8.32	0.89	0.59	0.30	13.37
Mast cell, donor3	11566-120D9	149.03	7.65	0.90	1.13	0.68	17.56
Mast cell, donor4	11567-120E1	167.01	8.51	0.89	0.35	0.18	10.99
Mast cell, expanded and stimulated, donor5	11940-126A5	128.97	7.87	1.77	0.78	0.22	7.43
Mast cell, expanded and stimulated, donor8	11942-126A7	131.91	7.00	2.92	1.75	0.00	8.76
Mast cell, expanded, donor5	11939-126A4	204.43	11.47	5.51	0.80	1.49	11.47
Mast cell, expanded, donor8	11941-126A6	269.46	17.41	2.51	0.84	1.51	10.04
Melanocyte - dark, donor1	11502-119F8	194.02	12.74	1.49	0.99	1.49	2.49
Melanocyte - dark, donor2	11582-120F7	78.21	4.15	0.35	0.35	0.00	1.38
Melanocyte - dark, donor3	11663-122F7	117.43	5.00	3.11	0.72	0.65	3.55
Melanocyte - light, donor1	11274-116H5	20.22	0.94	0.24	0.24	0.00	0.24
Melanocyte - light, donor2	11351-117H1	16.38	0.00	0.68	0.00	0.00	0.68
Melanocyte - light, donor3	11423-118G1	8.67	2.60	0.00	0.87	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	76.12	4.79	2.50	1.56	0.42	6.87
Melanocyte, donor2 (MC+2)	12739-135I3	76.65	3.50	1.34	1.34	0.00	1.61
Melanocyte, donor3 (MC+3)	12837-137B2	32.14	4.82	0.54	0.00	0.00	1.07
Meningeal Cells, donor1	11493-119E8	159.54	2.85	2.61	0.25	0.50	5.71
Meningeal Cells, donor2	11573-120E7	117.08	0.88	1.32	0.00	0.00	3.52
Meningeal Cells, donor3	11654-122E7	191.94	13.94	3.34	0.82	1.06	9.13
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	193.34	10.55	2.28	0.29	0.57	4.56
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	9.06	0.70	0.00	0.00	0.00	1.41
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	3.94	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	40.55	1.31	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	72.48	10.76	1.44	1.44	0.00	5.74
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	25.41	0.85	0.00	0.21	0.00	2.33
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	72.88	4.02	0.00	1.01	0.00	1.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	82.85	5.49	1.32	0.44	0.22	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	65.02	2.19	3.65	0.73	1.46	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	36.42	2.86	1.02	0.00	0.00	1.43
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	46.12	1.11	0.69	0.14	0.00	3.74
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	7.81	0.00	0.00	0.00	0.00	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	45.39	1.58	0.13	0.53	0.00	0.79
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	10.09	0.00	0.00	0.00	0.00	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	23.36	2.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	90.94	3.84	0.00	0.64	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	108.46	12.05	1.06	0.71	0.00	6.73
Mesenchymal stem cells - hepatic, donor0	11218-116B3	51.60	3.13	0.31	0.31	0.00	1.25
Mesenchymal stem cells - umbilical, donor0	11214-116A8	257.62	20.32	1.45	5.08	0.00	5.81
Mesothelial Cells, donor1	11247-116E5	1.86	0.00	0.27	0.27	0.00	0.80
Mesothelial Cells, donor2	12156-128G5	3.50	0.50	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	11.56	0.65	0.29	0.14	0.00	0.58
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	20.25	1.35	0.00	0.00	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	15.02	1.72	0.25	0.00	0.25	2.96
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	21.79	1.77	0.29	0.00	0.00	1.77
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	13.02	1.55	0.31	0.00	0.31	1.86
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	16.39	0.41	0.00	0.41	0.21	1.45
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	11.58	0.00	0.00	0.00	0.00	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	10.76	1.75	0.25	0.00	0.00	0.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	20.48	0.93	0.00	0.47	0.47	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	13.01	0.81	0.20	0.41	0.00	1.63
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	13.46	1.58	0.00	0.00	0.00	1.58
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	7.96	0.00	0.00	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	12.54	0.38	0.00	0.38	0.38	1.52
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	3.95	1.32	0.00	0.00	0.00	2.63
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	9.97	0.85	0.42	0.21	0.00	1.70
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	9.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	7.45	0.30	0.00	0.00	0.30	1.19
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	5.03	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	5.52	0.75	0.25	0.00	0.00	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	4.75	0.24	0.00	0.48	0.00	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	3.87	0.00	0.00	0.00	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	2.53	0.00	0.46	0.00	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	3.16	0.00	0.00	0.00	0.00	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	3.87	0.00	0.20	0.00	0.00	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	6.01	0.21	0.21	0.00	0.21	0.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	2.89	0.00	0.00	0.00	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	2.19	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	2.53	1.01	0.00	0.00	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	4.97	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	2.17	0.54	0.00	0.00	0.00	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	4.41	0.00	0.59	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	0.00	0.00	0.00	0.00	0.00	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	1.92	0.48	0.00	0.00	0.00	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	3.60	0.40	0.00	0.00	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	0.00	0.00	1.37	0.00	0.00	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	2.50	0.00	0.00	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	3.94	0.00	0.00	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	1.10	0.00	0.00	0.00	0.00	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	6.40	0.64	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	3.47	0.25	0.00	0.25	0.00	1.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	0.70	0.00	0.00	0.00	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	4.42	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	11.28	0.68	0.00	0.00	0.00	1.37
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	1.75	0.00	0.00	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	5.33	0.00	0.00	0.00	0.00	1.42
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	4.49	0.00	0.00	0.00	0.00	1.40
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	2.91	0.00	0.00	0.00	0.00	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	5.24	0.00	0.00	0.00	0.00	1.17
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	3.62	0.30	0.00	0.30	0.00	0.90
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	3.76	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	6.46	0.00	0.00	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	6.83	0.00	0.00	0.00	0.00	2.85
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	6.91	0.55	0.14	0.00	0.00	0.97
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	5.70	0.52	0.00	0.26	0.00	1.30
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	6.86	0.00	0.00	0.00	0.00	3.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	3.81	0.00	0.00	0.00	0.00	1.27
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	7.47	0.27	0.00	0.00	0.00	1.07
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	5.99	0.00	0.00	0.00	0.00	0.90
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	7.06	0.28	0.00	0.00	0.00	0.99
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	8.92	0.64	0.00	0.00	0.00	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	8.85	0.66	0.00	0.00	0.00	0.66
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	6.07	0.00	0.00	0.00	0.00	1.52
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	7.10	0.57	0.00	0.00	0.00	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	7.87	0.49	0.00	0.00	0.00	1.97
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	4.56	0.00	0.00	0.00	0.00	1.30
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	5.88	0.29	0.00	0.00	0.00	1.76
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	4.61	0.58	0.00	0.00	0.00	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	10.30	0.82	0.00	0.41	0.00	2.89
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	7.74	0.30	0.00	0.00	0.00	2.68
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	18.83	0.00	0.00	3.77	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	39.21	5.35	0.00	0.00	0.00	5.35
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	21.36	0.33	0.00	0.66	0.00	2.63
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	21.04	1.05	0.00	0.00	0.00	4.21
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	15.62	0.59	0.20	0.20	0.00	3.56
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	5.59	0.00	0.00	0.00	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	14.27	1.50	0.00	0.00	0.00	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	9.59	0.27	0.00	0.00	0.00	3.20
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	12.78	1.24	0.57	0.00	0.00	3.39
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	13.26	0.74	0.00	0.00	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	16.49	0.73	0.00	0.00	0.00	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	10.89	0.00	0.00	1.56	0.00	10.89
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	3.74	1.07	0.00	0.00	0.00	2.14
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	17.17	0.00	0.00	2.02	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	13.49	0.42	0.42	0.00	0.00	2.53
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	54.48	0.00	1.36	0.00	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	10.17	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	8.91	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	25.68	0.00	0.00	0.00	0.00	6.04
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	399.71	0.00	0.00	0.00	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	313.20	0.00	0.00	0.00	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	118.81	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	250.98	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	34.47	0.86	0.22	0.43	0.00	1.08
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	30.31	1.57	0.00	0.52	0.00	2.61
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	26.03	2.67	0.00	0.00	0.00	2.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	34.64	1.67	0.00	0.42	0.00	1.25
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	97.16	10.27	0.95	0.76	0.00	5.13
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	339.92	19.15	3.19	4.79	1.60	22.34
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	9.52	1.36	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	249.92	25.73	3.68	3.68	1.84	7.35
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	28.46	0.00	0.00	0.00	0.00	1.26
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	45.09	2.09	0.23	0.23	0.00	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	21.89	1.35	0.00	0.00	0.54	0.81
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	110.58	7.78	1.05	0.84	0.63	3.36
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	1113.47	77.94	11.13	22.27	11.13	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	13.40	0.00	0.00	0.00	0.00	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	19.76	1.35	0.00	0.00	0.27	1.62
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	18.13	0.91	0.00	0.23	0.00	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	11.10	0.82	0.00	0.00	0.00	1.14
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	53.95	3.10	1.09	0.55	0.36	2.19
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	16.44	4.24	0.53	0.00	0.00	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	18.01	1.20	0.00	0.00	0.00	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	38.07	2.30	0.00	0.00	1.31	1.97
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	13.34	0.98	0.16	0.16	0.16	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	50.62	3.53	0.35	0.88	0.35	3.70
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	17.58	2.11	0.00	0.00	0.00	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	9.19	1.38	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	10.60	2.25	0.32	0.64	0.32	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	62.42	3.79	0.69	0.69	0.00	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	166.88	20.23	5.06	0.00	2.53	10.11
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	38.76	2.01	0.45	0.89	0.22	1.56
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	11.01	0.42	0.00	0.85	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	14.95	1.66	0.24	0.00	0.24	2.37
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	7.30	0.00	0.00	0.00	0.00	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	379.17	27.08	0.00	0.00	9.03	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	6.66	0.33	0.67	0.00	0.00	1.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	17.13	0.90	0.00	0.00	0.00	1.35
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	8.33	0.00	0.00	0.00	0.00	1.19
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	13.00	0.93	0.00	0.00	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	9.46	0.38	0.00	0.00	0.38	1.14
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	9.45	0.00	0.00	0.00	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	10.89	0.44	0.00	0.00	0.00	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	21.71	2.26	0.00	0.00	0.45	4.52
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	3.53	0.88	0.00	0.00	0.00	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	9.97	0.66	0.00	0.00	0.00	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	7.94	2.48	0.00	0.00	0.00	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	6.13	0.38	0.00	0.00	0.00	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	20.26	0.60	0.00	0.00	0.00	2.42
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	18.34	1.55	0.00	0.00	0.00	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	14.23	0.00	0.68	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	112.41	5.11	0.00	0.00	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	10.97	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	4.72	0.31	0.00	0.00	0.00	0.94
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	6.05	0.30	0.61	0.00	0.30	1.21
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	9.49	0.79	0.00	0.00	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	41.94	1.13	0.00	1.13	0.00	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	121.39	0.00	5.06	5.06	5.06	5.06
Myoblast, donor1	11241-116D8	42.98	2.86	0.25	0.25	0.25	0.99
Myoblast, donor2	11322-117D8	62.33	4.41	1.34	0.38	0.00	3.26
Myoblast, donor3	11398-118D3	93.33	8.58	0.17	0.84	0.17	3.87
NK T cell leukemia cell line:KHYG-1	10777-110G3	1833.35	52.39	8.17	15.91	2.63	18.10
Natural Killer Cells, donor1	11230-116C6	152.22	8.92	1.54	0.31	2.77	7.07
Natural Killer Cells, donor2	11311-117C6	146.56	6.33	0.90	4.82	0.30	4.82
Natural Killer Cells, donor3	11387-118C1	127.92	6.99	2.21	2.02	0.37	5.89
Neural stem cells, donor1	11275-116H6	208.33	16.70	2.90	0.73	0.00	9.44
Neural stem cells, donor2	11352-117H2	300.40	7.70	1.93	0.00	5.78	7.70
Neurons, donor1	11494-119E9	195.72	15.93	1.14	2.28	0.00	7.97
Neurons, donor2	11574-120E8	90.93	7.49	1.10	0.88	0.88	5.50
Neurons, donor3	11655-122E8	115.10	11.51	0.82	2.47	3.29	7.40
Neutrophils, donor1	11233-116C9	330.37	9.28	0.93	0.93	0.00	2.78
Neutrophils, donor2	11314-117C9	246.40	0.00	2.90	8.70	0.00	5.80
Neutrophils, donor3	11390-118C4	722.02	25.04	4.89	0.61	0.61	3.67
Nucleus Pulposus Cell, donor1	11252-116F1	84.54	5.70	0.95	0.59	0.00	2.02
Nucleus Pulposus Cell, donor2	11409-118E5	18.23	2.28	0.00	0.65	0.00	1.63
Nucleus Pulposus Cell, donor3	11462-119B4	32.89	0.80	0.20	0.20	0.00	1.80
Olfactory epithelial cells, donor1	11933-125I7	14.32	1.10	0.00	0.41	0.00	0.96
Olfactory epithelial cells, donor2	11934-125I8	32.71	1.59	0.00	2.03	0.14	0.72
Olfactory epithelial cells, donor3	11935-125I9	18.39	0.79	0.23	0.45	0.00	1.14
Olfactory epithelial cells, donor4	11936-126A1	29.51	2.43	0.39	0.29	0.29	2.43
Oligodendrocyte - precursors, donor1	11496-119F2	90.87	8.43	0.00	0.60	0.00	5.42
Osteoblast - differentiated, donor1	11276-116H7	12.34	0.43	0.00	0.21	0.21	0.85
Osteoblast - differentiated, donor2	11353-117H3	11.43	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	21.72	0.62	0.62	0.00	0.00	2.48
Osteoblast, donor1	11277-116H8	35.76	1.17	0.39	0.20	0.00	1.37
Osteoblast, donor2	11354-117H4	257.05	11.24	5.62	2.11	0.00	8.43
Osteoblast, donor3	11426-118G4	79.27	5.15	0.53	0.53	0.53	2.84
Pancreatic stromal cells, donor1	11249-116E7	128.12	10.19	1.10	1.10	0.51	4.46
Pericytes, donor1	11491-119E6	5.12	0.11	0.11	0.00	0.00	0.22
Pericytes, donor2	11571-120E5	7.02	0.23	0.00	0.00	0.23	0.68
Pericytes, donor3	11652-122E5	30.92	2.03	0.20	0.61	0.20	0.81
Perineurial Cells, donor1	11499-119F5	128.28	9.38	1.36	0.57	0.45	6.78
Perineurial Cells, donor2	11579-120F4	99.37	3.77	0.37	0.00	0.18	1.84
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	167.98	7.97	2.23	0.64	0.64	10.84
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	97.46	4.90	0.49	2.94	0.00	3.92
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	108.06	7.38	0.78	1.55	0.52	9.71
Placental Epithelial Cells, donor1	11278-116H9	33.96	2.63	0.24	0.00	0.48	1.20
Placental Epithelial Cells, donor2	11355-117H5	55.44	0.00	1.11	0.00	0.00	2.22
Placental Epithelial Cells, donor3	11427-118G5	44.96	4.52	1.37	0.00	0.39	1.96
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	13.61	0.00	0.32	0.00	0.00	1.58
Preadipocyte - breast, donor1	11467-119B9	24.01	1.31	0.00	0.19	0.00	1.69
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	33.81	2.09	0.00	0.26	0.00	2.09
Preadipocyte - breast, donor2	11328-117E5	26.79	0.90	0.00	0.23	0.00	2.48
Preadipocyte - omental, donor1	11468-119C1	20.25	1.07	0.00	0.00	0.00	1.39
Preadipocyte - omental, donor2	11329-117E6	39.28	0.87	0.00	0.44	0.00	1.75
Preadipocyte - omental, donor3	11403-118D8	13.61	1.00	0.00	0.00	0.14	1.43
Preadipocyte - perirenal, donor1	11469-119C2	6.89	0.00	0.00	0.00	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	15.05	0.61	0.00	0.31	0.31	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	144.85	13.28	1.59	2.83	0.00	6.73
Preadipocyte - subcutaneous, donor3	11428-118G6	69.31	6.13	0.51	0.68	0.17	2.21
Preadipocyte - visceral, donor1	11280-116I2	172.14	14.90	1.96	0.47	0.56	8.20
Preadipocyte - visceral, donor2	11357-117H7	67.65	4.14	0.46	2.30	0.00	5.06
Preadipocyte - visceral, donor3	11429-118G7	89.13	4.08	1.78	1.36	0.42	5.22
Prostate Epithelial Cells (polarized), donor1	11253-116F2	198.67	6.34	0.15	2.11	0.45	6.18
Prostate Epithelial Cells, donor2	11331-117E8	6.23	0.41	0.14	0.14	0.00	0.27
Prostate Epithelial Cells, donor3	11404-118D9	21.00	0.61	0.06	0.67	0.00	0.67
Prostate Stromal Cells, donor1	11254-116F3	223.02	14.58	0.80	1.59	0.23	4.21
Prostate Stromal Cells, donor2	11332-117E9	199.74	10.76	1.79	7.35	0.18	4.66
Prostate Stromal Cells, donor3	11405-118E1	20.96	0.73	0.21	0.73	0.00	1.04
Renal Cortical Epithelial Cells, donor1	11516-119H4	34.31	1.09	0.00	0.36	0.00	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	85.53	8.25	1.52	0.76	0.07	3.74
Renal Epithelial Cells, donor1	11517-119H5	34.49	0.51	0.51	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	39.83	2.85	0.71	0.71	0.00	2.85
Renal Epithelial Cells, donor3	11678-122H4	119.63	9.32	1.27	1.27	0.11	6.46
Renal Glomerular Endothelial Cells, donor1	11514-119H2	27.23	0.00	0.68	0.68	2.04	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	56.87	0.81	0.94	0.81	0.81	2.16
Renal Glomerular Endothelial Cells, donor3	11675-122H1	150.97	13.76	1.33	2.66	0.22	5.55
Renal Glomerular Endothelial Cells, donor4	11783-124B1	7.32	0.00	0.67	0.00	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	36.53	1.98	1.32	0.00	0.22	1.32
Renal Mesangial Cells, donor2	11598-120H5	43.89	1.88	0.00	0.63	0.00	1.25
Renal Mesangial Cells, donor3	11679-122H5	9.99	0.28	0.28	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	115.42	4.03	2.42	0.54	0.00	3.49
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	43.01	2.11	0.00	0.42	0.00	2.11
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	76.75	6.17	2.51	0.58	0.19	2.12
Retinal Pigment Epithelial Cells, donor0	11215-116A9	268.88	26.19	1.81	3.63	0.00	11.67
Retinal Pigment Epithelial Cells, donor1	11528-119I7	106.88	3.13	0.85	0.28	0.00	2.27
Retinal Pigment Epithelial Cells, donor2	11608-120I6	65.86	3.09	0.00	1.03	0.00	2.06
Retinal Pigment Epithelial Cells, donor3	11689-122I6	63.98	2.51	0.00	0.00	0.00	1.51
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	69.89	4.68	1.07	0.27	0.40	4.28
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	219.78	25.91	13.40	2.68	3.57	9.83
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	345.08	55.04	13.21	13.21	7.15	26.97
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	688.53	83.53	23.78	11.02	15.08	43.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	407.24	9.36	10.92	0.78	2.34	23.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	248.07	21.65	8.44	4.77	1.29	9.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	302.05	23.09	10.48	2.23	2.12	14.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	454.25	27.41	15.13	3.97	2.73	21.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	274.81	21.21	8.16	5.48	0.93	12.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	298.16	27.97	12.48	9.01	1.62	14.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	236.30	9.58	5.61	0.96	0.96	15.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	275.32	27.08	8.32	5.14	1.51	12.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	251.94	23.47	10.75	3.23	1.08	15.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	230.82	8.32	5.88	2.73	1.29	13.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	263.35	22.11	5.90	4.61	0.86	11.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	238.31	18.59	9.74	5.09	1.11	8.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	217.75	6.31	4.21	2.68	1.34	14.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	265.42	21.52	6.99	2.89	0.93	12.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	314.74	29.31	9.40	2.82	1.13	14.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	237.15	6.77	5.84	0.53	0.40	14.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	310.13	28.03	7.79	6.04	1.56	15.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	261.42	22.72	6.49	6.11	0.95	11.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	234.63	9.18	5.45	0.75	0.96	15.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	255.64	16.82	5.05	5.33	0.56	10.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	236.87	21.19	6.67	4.96	0.68	15.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	193.27	6.20	3.83	1.09	0.36	12.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	239.01	18.15	4.05	4.41	0.61	13.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	243.66	17.86	9.13	4.84	0.27	13.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	212.52	7.31	6.13	1.18	0.94	15.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	252.18	21.43	6.15	4.37	0.79	12.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	207.19	19.18	7.95	3.98	1.17	12.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	185.58	7.05	3.11	1.45	1.04	12.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	265.67	13.05	7.08	9.29	1.55	13.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	167.11	14.41	7.73	3.55	0.63	11.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	211.70	9.56	6.59	2.02	0.81	15.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	257.15	22.31	9.54	1.02	1.53	12.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	195.49	17.54	8.48	3.86	1.16	10.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	262.20	7.22	6.19	2.58	1.72	14.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	248.14	23.59	9.46	2.19	0.82	11.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	286.31	25.45	9.52	7.55	1.97	16.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	212.70	6.99	8.18	1.19	1.19	11.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	342.52	25.15	9.03	5.03	1.78	13.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	256.69	30.12	9.06	2.13	0.80	14.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	286.07	7.60	8.02	0.69	2.07	11.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	260.96	24.76	11.91	4.76	1.43	14.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	305.74	35.47	12.50	2.42	1.61	14.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	293.26	10.08	11.02	1.04	2.35	13.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	306.04	20.26	16.77	9.08	1.05	14.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	227.87	20.55	12.69	2.72	1.21	9.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	227.64	11.14	12.61	0.73	2.33	11.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	608.99	56.91	26.93	3.20	6.26	24.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	275.01	27.99	9.73	3.04	6.69	14.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	211.58	7.53	11.75	0.00	2.71	11.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	237.95	20.81	11.31	2.26	3.62	11.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	289.06	40.74	21.27	4.19	5.99	13.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	240.87	5.79	11.45	1.30	4.96	12.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	203.63	20.70	13.23	0.85	4.70	7.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	231.38	30.05	19.83	3.00	8.41	16.83
Schwann Cells, donor1	11498-119F4	43.26	0.56	2.26	0.38	0.00	0.75
Schwann Cells, donor2	11578-120F3	180.33	6.80	3.40	10.21	0.00	6.80
Schwann Cells, donor3	11659-122F3	73.61	5.92	0.88	2.19	0.22	1.53
Sebocyte, donor1	11220-116B5	48.20	2.74	0.55	0.55	0.00	4.38
Sebocyte, donor2	11301-117B5	28.03	2.76	0.00	0.00	0.00	2.30
Sebocyte, donor3	11378-118B1	24.94	1.44	0.21	0.41	0.21	1.24
Sertoli Cells, donor1	11255-116F4	127.56	8.28	0.00	3.31	0.00	0.00
Sertoli Cells, donor2	11333-117F1	36.72	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	53.75	2.90	0.18	0.26	0.35	3.43
Skeletal Muscle Cells, donor2	11358-117H8	7.95	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	66.05	0.00	2.51	0.00	1.67	6.69
Skeletal Muscle Cells, donor4	11451-119A2	172.96	6.60	2.04	2.20	0.63	8.80
Skeletal Muscle Cells, donor5	11455-119A6	176.74	6.69	1.04	1.93	0.00	6.54
Skeletal Muscle Cells, donor6	11459-119B1	200.53	4.77	2.31	2.00	0.46	10.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	234.75	13.10	0.76	2.39	0.13	4.91
Skeletal Muscle Satellite Cells, donor2	11321-117D7	200.76	13.56	0.57	2.85	0.00	3.85
Skeletal Muscle Satellite Cells, donor3	11397-118D2	188.99	18.25	1.88	1.79	0.20	10.22
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	55.77	3.37	0.51	0.51	0.08	3.03
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	74.55	1.45	0.00	0.00	0.72	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	15.14	0.69	0.28	0.00	0.41	0.41
Skin - palm, donor1	10286-104F7	161.17	2.69	0.00	0.00	0.00	8.06
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	5.48	0.58	0.00	0.00	0.00	0.58
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	19.63	0.82	0.00	0.00	0.00	4.09
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	22.33	0.65	0.00	0.13	0.00	0.78
Small Airway Epithelial Cells, donor1	11256-116F5	41.01	1.25	0.14	0.42	0.00	1.25
Small Airway Epithelial Cells, donor2	11334-117F2	29.12	1.27	0.00	0.98	0.00	0.84
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	72.74	4.86	0.42	0.21	0.42	2.75
Small Airway Epithelial Cells, donor3	11406-118E2	38.30	1.87	0.30	0.22	0.00	1.50
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	20.68	0.31	0.62	0.00	0.31	0.93
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	19.57	0.44	0.00	0.22	0.00	0.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	18.81	0.59	0.59	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	16.35	4.20	0.22	0.44	0.00	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	6.69	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	21.63	1.55	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	28.02	0.00	0.00	0.00	0.00	2.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	3.46	0.13	0.13	0.00	0.00	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	37.02	2.22	0.22	1.33	0.00	1.11
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	31.50	0.64	0.26	0.13	0.13	1.54
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	65.12	5.86	0.65	0.33	0.00	0.98
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	57.29	5.32	1.18	0.00	0.30	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	10.25	1.28	0.28	0.14	0.00	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	18.54	0.33	1.30	0.16	0.00	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	36.53	3.04	0.30	0.30	0.00	2.74
Smooth Muscle Cells - Carotid, donor1	11285-116I7	15.91	1.01	0.25	0.25	0.25	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	48.97	0.00	12.24	0.00	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	9.06	0.00	0.00	0.48	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	66.36	5.31	0.88	0.44	0.00	2.95
Smooth Muscle Cells - Colonic, donor2	11320-117D6	76.84	3.01	1.08	1.29	0.00	2.58
Smooth Muscle Cells - Colonic, donor3	11396-118D1	92.05	6.93	0.84	0.94	0.10	3.36
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	8.51	0.77	0.00	0.00	0.15	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	5.39	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	12.85	0.00	0.30	0.00	0.00	1.49
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	32.43	1.37	0.34	0.00	0.00	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	76.80	4.08	0.24	1.10	0.08	1.41
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	12.68	1.11	0.00	0.30	0.00	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	18.89	0.68	0.00	0.46	0.00	1.14
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	6.64	0.60	0.00	0.00	0.00	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	356.32	29.14	2.12	2.65	0.00	14.57
Smooth Muscle Cells - Prostate, donor1	11257-116F6	132.09	2.93	1.07	0.80	0.53	3.06
Smooth Muscle Cells - Prostate, donor2	11335-117F3	61.36	2.63	0.25	1.38	0.13	1.75
Smooth Muscle Cells - Prostate, donor3	11465-119B7	28.16	2.03	0.00	0.25	0.25	2.54
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	36.03	4.37	0.45	0.15	0.45	2.26
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	12.75	0.00	0.75	0.00	0.00	2.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	41.35	3.88	0.00	2.58	0.00	2.58
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	34.42	3.26	0.00	0.00	0.47	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	15.15	2.02	0.00	0.00	0.00	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	5.95	0.63	0.00	0.00	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	10.62	0.29	0.59	0.00	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	262.75	16.24	1.33	0.58	0.42	6.58
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	45.78	1.87	0.47	0.00	0.00	2.80
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	9.79	1.01	0.29	0.00	0.00	0.72
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	44.62	3.31	0.25	0.25	0.25	2.04
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	36.48	0.94	0.75	0.19	0.38	1.32
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	281.17	16.77	0.98	1.68	0.14	7.83
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	49.02	2.60	0.34	0.08	0.00	2.43
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	9.52	0.95	0.00	0.00	0.00	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	12.97	0.73	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	8.18	0.44	0.22	0.00	0.00	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	182.28	10.83	1.17	0.59	0.00	4.68
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	26.63	1.55	0.19	0.39	0.00	1.17
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	9.52	0.79	0.00	0.26	0.00	1.32
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	38.31	4.09	0.00	0.37	0.37	5.58
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	21.92	1.44	0.36	0.00	0.00	1.08
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	11.07	1.42	0.28	0.00	0.28	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	196.15	9.06	1.18	3.15	0.39	5.51
Smooth muscle cells - airway, control, donor1	11966-126D4	28.19	1.27	0.25	0.51	0.00	1.78
Smooth muscle cells - airway, control, donor2	11967-126D5	13.18	2.80	0.00	0.40	0.40	1.60
Smooth muscle cells - airway, control, donor3	11968-126D6	19.23	2.09	0.42	0.84	0.00	2.09
Smooth muscle cells - airway, control, donor4	11969-126D7	32.09	2.75	0.46	1.38	0.46	2.75
Synoviocyte, donor1	11291-117A4	12.62	1.35	0.17	0.17	0.00	0.34
Synoviocyte, donor2	11368-117I9	56.99	3.02	0.00	1.17	0.34	1.34
Synoviocyte, donor3	11440-118H9	23.90	0.67	0.00	0.22	0.00	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	95.41	6.07	3.57	0.00	1.07	2.86
Trabecular Meshwork Cells, donor2	11612-122A1	51.53	0.00	0.00	1.98	0.00	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	58.58	3.01	0.69	0.00	0.69	0.93
Tracheal Epithelial Cells, donor1	11292-117A5	48.82	3.37	0.14	0.29	0.00	2.22
Tracheal Epithelial Cells, donor2	11369-118A1	16.24	0.39	0.00	0.77	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	26.92	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	69.14	3.32	1.11	0.62	0.12	3.08
Urethra, donor2	10319-105A4	30.57	0.00	0.00	0.00	0.00	1.80
Urothelial Cells, donor1	11520-119H8	5.31	0.27	0.00	0.27	0.00	0.27
Urothelial Cells, donor2	11600-120H7	2.80	0.00	0.00	0.40	0.00	0.00
Urothelial Cells, donor3	11681-122H7	4.58	0.00	0.23	0.23	0.00	0.92
Urothelial cells, donor0	11216-116B1	19.84	1.78	0.45	0.89	0.00	3.34
Whole blood (ribopure), donor090309, donation1	12179-129A1	296.30	1.78	2.67	0.89	0.00	9.79
Whole blood (ribopure), donor090309, donation2	12180-129A2	287.35	4.29	2.86	1.43	0.00	10.01
Whole blood (ribopure), donor090309, donation3	12181-129A3	195.09	6.16	2.05	3.42	0.00	7.53
Whole blood (ribopure), donor090325, donation1	12176-128I7	146.69	8.61	1.38	0.69	0.69	9.99
Whole blood (ribopure), donor090325, donation2	12177-128I8	164.43	8.13	1.74	1.74	0.58	9.30
Whole blood (ribopure), donor090612, donation1	12182-129A4	284.26	2.08	5.21	1.04	0.00	11.45
Whole blood (ribopure), donor090612, donation2	12183-129A5	257.90	6.42	0.92	0.00	0.00	16.52
Whole blood (ribopure), donor090612, donation3	12184-129A6	158.84	11.87	1.83	6.39	0.91	10.04
Wilms' tumor cell line:G-401	10809-111A8	258.81	10.61	0.86	1.97	0.12	10.86
Wilms' tumor cell line:HFWT	10597-108E3	80.08	4.40	0.88	1.76	0.00	6.16
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	435.18	27.09	2.79	4.19	1.12	16.20
achilles tendon, donor2	10292-104G4	51.66	4.13	0.00	2.07	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	806.17	50.23	7.14	9.94	5.35	30.85
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	1936.34	40.40	6.04	6.04	1.86	25.07
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	2727.91	108.74	19.11	7.24	9.14	33.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	887.64	69.12	16.05	7.35	6.80	49.52
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	421.91	16.30	1.12	8.99	0.56	11.52
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	950.40	78.25	8.25	5.29	1.48	40.82
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	591.79	22.05	2.72	5.17	0.82	10.62
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	564.46	14.98	0.88	7.49	0.00	5.73
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	479.01	24.50	2.04	6.94	1.63	22.46
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	733.11	29.12	4.27	8.54	1.16	13.98
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	573.16	19.69	3.86	6.99	0.74	15.82
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	518.77	7.80	0.00	0.00	3.90	11.70
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	643.47	38.11	5.11	10.22	1.16	39.74
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	1385.38	73.27	4.92	12.69	2.07	34.17
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	968.79	40.62	6.72	30.10	2.05	28.64
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	776.61	28.82	4.65	6.97	0.46	8.83
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	626.34	13.98	3.70	2.47	1.23	6.58
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	343.17	4.60	1.84	0.61	0.31	7.37
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	690.41	36.27	5.55	4.27	1.28	15.36
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	692.42	33.67	8.49	1.52	0.91	13.65
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	743.06	29.61	6.26	1.68	1.20	15.89
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	550.39	22.05	1.78	8.46	0.67	19.82
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	975.29	35.69	3.00	8.34	0.67	22.35
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	2025.44	66.90	14.87	1.86	3.72	59.46
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	865.19	33.90	5.27	3.77	2.26	21.47
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	677.31	23.55	3.05	7.41	0.87	23.99
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	549.22	11.25	0.00	0.00	0.00	13.12
adenocarcinoma cell line:IM95m	10796-110I4	200.88	12.01	0.71	2.35	0.00	9.18
adipose tissue, adult, pool1	10010-101C1	62.98	3.26	2.33	0.47	2.33	2.48
adipose, donor1	10184-103D4	860.85	51.60	2.93	12.31	0.59	34.01
adipose, donor2	10185-103D5	262.37	14.60	1.62	5.27	0.00	10.95
adipose, donor3	10186-103D6	304.15	13.89	0.54	6.53	0.54	8.17
adipose, donor4	10187-103D7	266.09	50.27	0.87	16.47	0.00	14.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	124.05	14.84	0.32	0.79	0.00	20.52
adrenal gland, adult, pool1	10081-102A9	21.83	3.64	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	671.70	66.97	6.94	4.80	2.27	34.95
alveolar cell carcinoma cell line:SW 1573	10708-109H6	240.46	11.79	0.71	2.50	0.00	5.36
amniotic membrane cells, donor1	12235-129G3	34.31	1.62	0.23	0.70	0.00	3.25
amniotic membrane cells, donor2	12236-129G4	189.00	16.57	6.76	2.37	2.70	6.42
amniotic membrane cells, donor3	12237-129G5	54.21	2.65	0.88	0.00	0.29	7.95
amygdala - adult, donor10196	10167-103B5	33.20	0.00	0.00	0.00	0.00	5.93
amygdala, adult, donor10252	10151-102I7	29.81	5.07	0.41	0.20	0.41	3.85
amygdala, newborn, donor10223	10360-105E9	25.82	1.61	0.00	0.00	0.00	1.61
anaplastic carcinoma cell line:8305C	10428-106D5	173.04	7.64	1.27	0.89	0.13	4.58
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	249.30	20.08	2.43	4.19	0.44	17.21
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	1290.05	67.81	0.67	6.68	0.33	13.36
aorta, adult, pool1	10052-101G7	62.96	2.55	0.39	1.37	0.20	6.08
appendix, adult	10189-103D9	234.42	29.11	3.88	2.33	1.55	22.90
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	282.37	24.42	4.13	2.06	1.38	9.97
artery, adult	10190-103E1	38.04	5.43	2.72	1.36	2.72	8.15
astrocytoma cell line:TM-31	10425-106D2	165.15	12.31	1.88	1.01	0.43	6.95
b cell line:RPMI1788	10427-106D4	437.33	63.64	4.31	2.23	0.30	56.36
basal cell carcinoma cell line:TE 354.T	10702-109G9	14.15	1.39	0.28	0.28	0.00	1.66
bile duct carcinoma cell line:HuCCT1	10432-106D9	320.12	13.40	0.99	0.79	0.30	4.47
bile duct carcinoma cell line:TFK-1	10496-107C1	53.73	1.51	0.84	0.67	0.00	1.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	389.23	21.81	1.68	5.03	0.00	5.59
bladder, adult, pool1	10011-101C2	100.71	6.52	0.54	0.98	0.22	7.50
blood, adult, pool1	10053-101G8	197.10	15.50	0.00	6.64	2.21	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	157.57	5.14	4.28	0.00	0.86	5.14
bone marrow, adult	10192-103E3	96.50	2.02	2.70	4.72	0.67	1.35
brain, adult, donor1	10084-102B3	13.33	2.05	1.03	0.00	0.00	5.13
brain, adult, pool1	10012-101C3	40.87	3.34	0.11	0.33	0.11	6.90
brain, fetal, pool1	10085-102B4	10.69	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	215.73	15.53	0.99	4.96	0.00	5.62
breast carcinoma cell line:MDA-MB-453	10419-106C5	236.79	17.23	1.75	0.50	0.50	7.61
breast, adult, donor1	10080-102A8	51.77	3.79	1.26	0.00	6.31	1.89
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	98.71	11.31	1.27	1.65	0.13	8.64
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	229.75	31.23	3.09	4.02	0.00	24.43
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	88.40	18.88	1.61	1.38	0.23	34.30
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	220.54	9.93	2.66	4.12	0.24	5.57
carcinoid cell line:NCI-H1770	10703-109H1	303.26	35.73	5.64	1.88	1.88	24.45
carcinoid cell line:NCI-H727	10735-110B6	166.91	11.16	2.08	1.09	0.11	5.25
carcinoid cell line:SK-PN-DW	10719-109I8	618.58	45.32	6.02	5.39	3.17	10.46
carcinosarcoma cell line:JHUCS-1	10642-109A3	626.58	50.84	26.09	22.36	26.88	38.06
caudate nucleus - adult, donor10196	10177-103C6	64.47	4.61	0.00	1.15	0.00	18.42
caudate nucleus, adult, donor10252	10164-103B2	57.23	7.36	0.67	0.84	0.17	4.35
caudate nucleus, adult, donor10258	10379-105H1	34.39	5.35	0.76	0.00	0.00	3.06
caudate nucleus, newborn, donor10223	10354-105E3	46.15	1.46	0.00	0.73	0.37	2.56
cerebellum - adult, donor10196	10173-103C2	40.79	5.83	0.00	0.00	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	40.35	6.83	0.21	1.07	0.21	5.34
cerebellum, adult, pool1	10083-102B2	21.04	1.72	0.00	1.03	0.00	2.76
cerebellum, newborn, donor10223	10357-105E6	68.91	4.15	0.00	0.00	0.00	1.66
cerebral meninges, adult	10188-103D8	51.18	4.54	0.50	0.76	0.00	4.29
cerebrospinal fluid, donor2	10294-104G6	12.43	1.46	0.73	0.73	0.73	3.65
cervical cancer cell line:D98-AH2	10552-107I3	211.22	18.12	1.29	0.58	0.86	6.04
cervical cancer cell line:ME-180	10553-107I4	113.18	6.63	0.83	0.00	0.17	3.98
cervix, adult, pool1	10013-101C4	77.38	6.93	1.36	0.52	0.84	9.97
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	43.89	1.67	0.70	0.42	0.00	0.98
chondrosarcoma cell line:SW 1353	10700-109G7	79.68	2.61	1.31	0.00	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	384.01	18.27	0.99	3.36	0.12	9.82
choriocarcinoma cell line:SCH	10785-110H2	191.96	7.02	0.12	2.83	0.25	3.70
choriocarcinoma cell line:T3M-3	10618-108G6	149.90	5.69	0.24	0.71	0.00	9.25
chorionic membrane cells, donor1	12238-129G6	39.32	1.14	0.28	0.28	0.00	2.28
chorionic membrane cells, donor2	12239-129G7	82.93	3.58	1.39	0.89	0.50	2.98
chorionic membrane cells, donor3	12240-129G8	48.35	1.10	0.55	1.10	0.00	4.95
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	1307.69	26.25	9.09	44.43	2.02	22.22
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	537.88	19.21	1.54	2.50	0.77	7.30
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	929.22	19.43	6.97	5.91	0.84	7.81
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	627.62	31.33	1.54	7.96	0.51	33.13
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	713.54	23.95	4.11	6.77	0.48	21.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	693.50	30.54	5.29	5.70	0.00	29.52
chronic myelogenous leukemia cell line:K562	10454-106G4	592.15	17.37	3.24	3.83	0.00	11.48
chronic myelogenous leukemia cell line:KU812	10409-106B4	1616.40	60.73	3.91	5.21	2.09	16.42
clear cell carcinoma cell line:JHOC-5	10638-108I8	136.69	18.06	4.80	7.31	0.23	40.23
clear cell carcinoma cell line:TEN	10636-108I6	340.59	34.53	3.64	0.69	1.04	17.52
colon carcinoma cell line:CACO-2	10513-107D9	423.74	15.74	2.56	1.28	0.92	11.53
colon carcinoma cell line:COLO-320	10420-106C6	618.39	79.44	3.04	4.56	0.38	53.97
colon, adult, donor1	10082-102B1	69.02	7.14	1.19	1.19	0.00	2.38
colon, adult, pool1	10014-101C5	111.98	5.76	1.53	0.12	0.71	5.88
colon, fetal, donor1	10070-101I7	162.53	16.07	0.00	1.24	0.62	5.56
common myeloid progenitor CMP, donor1	12130-128D6	944.20	36.67	4.58	0.00	0.00	27.50
common myeloid progenitor CMP, donor2	12134-128E1	751.10	0.00	0.00	0.00	0.00	25.04
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	550.29	24.65	0.00	0.85	0.42	21.25
cord blood derived cell line:COBL-a 24h infection	10453-106G3	459.28	36.07	0.60	1.36	0.15	28.22
cord blood derived cell line:COBL-a untreated	10449-106F8	465.62	32.86	1.41	1.69	0.56	31.59
corpus callosum, adult, pool1	10042-101F6	47.10	3.43	0.33	0.11	0.00	4.64
cruciate ligament, donor2	10295-104G7	52.68	6.48	0.00	5.67	0.81	3.24
diaphragm, fetal, donor1	10069-101I6	27.29	3.21	0.80	0.00	0.80	3.21
diencephalon, adult	10193-103E4	27.60	3.60	0.00	0.24	0.00	6.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	885.61	79.22	3.67	43.17	2.30	42.48
ductal cell carcinoma cell line:KLM-1	10438-106E6	233.10	13.59	1.28	1.54	0.26	15.64
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	91.23	6.26	0.72	0.72	0.00	2.41
ductus deferens, adult	10196-103E7	29.90	1.99	1.50	0.50	1.99	3.49
duodenum, fetal, donor1, tech_rep1	10071-101I8	50.41	4.32	2.88	1.44	0.00	5.76
duodenum, fetal, donor1, tech_rep2	10071-101I8	102.99	2.94	1.47	3.68	0.00	12.51
dura mater, adult, donor1	10041-101F5	232.90	7.19	1.24	0.91	0.74	4.87
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	328.45	10.66	3.55	1.33	2.00	2.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	262.37	13.61	1.29	0.72	1.43	4.73
embryonic pancreas cell line:1B2C6	10604-108F1	81.39	8.02	1.23	2.47	1.23	9.25
embryonic pancreas cell line:1C3D3	10605-108F2	37.23	4.24	0.30	0.00	0.00	5.45
embryonic pancreas cell line:1C3IKEI	10606-108F3	63.29	4.63	1.54	0.31	0.31	7.41
embryonic pancreas cell line:2C6	10603-108E9	81.43	10.51	0.00	0.00	0.00	5.25
endometrial carcinoma cell line:OMC-2	10497-107C2	70.73	6.03	0.34	0.00	0.00	3.35
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	152.24	11.60	1.45	1.99	0.36	14.68
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	77.35	5.31	0.64	1.77	0.00	6.59
epidermoid carcinoma cell line:A431	10426-106D3	592.81	43.46	3.22	1.56	0.56	13.12
epidermoid carcinoma cell line:Ca Ski	10431-106D8	365.37	34.76	3.08	1.43	0.77	15.18
epididymis, adult	10197-103E8	63.63	6.07	0.63	1.05	0.63	7.33
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	255.29	10.47	2.31	4.26	2.31	6.21
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	213.14	6.29	0.00	1.18	0.39	3.93
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	280.84	31.71	1.97	5.77	0.26	6.95
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	414.15	39.96	1.97	4.04	0.10	6.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	232.46	28.23	2.02	4.03	0.22	5.83
esophagus, adult, pool1	10015-101C6	103.74	7.33	1.70	0.64	0.64	6.26
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	68.63	7.39	0.00	0.00	0.00	8.64
eye - muscle inferior rectus, donor1	10272-104E2	149.70	2.41	0.00	0.00	0.00	4.83
eye - muscle lateral, donor2	10298-104H1	48.40	0.00	2.10	0.00	0.00	6.31
eye - muscle medial, donor2	10299-104H2	40.18	1.49	0.00	0.00	0.00	7.44
eye - muscle superior, donor2	10297-104G9	36.69	5.73	0.00	0.00	0.00	3.44
eye - vitreous humor, donor1	10268-104D7	183.63	8.74	0.00	5.83	0.00	11.66
eye, fetal, donor1	10054-101G9	94.83	5.59	0.25	1.02	1.02	9.41
fibrosarcoma cell line:HT-1080	10758-110E2	178.49	8.33	0.77	1.41	0.13	6.54
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	173.32	15.91	1.42	3.56	0.24	7.12
frontal lobe, adult, pool1	10040-101F4	39.88	3.10	0.09	0.28	0.09	4.22
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	352.19	32.13	1.50	5.70	0.60	5.40
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	64.74	6.22	0.09	0.18	0.18	6.03
gall bladder, adult	10198-103E9	55.05	2.66	0.72	1.21	0.00	4.35
gamma delta positive T cells, donor1	11937-126A2	96.10	11.81	4.29	0.00	0.54	19.33
gamma delta positive T cells, donor2	11938-126A3	117.65	9.34	1.49	1.12	0.37	17.18
gastric adenocarcinoma cell line:MKN1	10614-108G2	116.59	5.70	0.21	1.90	0.21	1.27
gastric adenocarcinoma cell line:MKN45	10612-108F9	91.68	4.64	1.16	1.74	0.00	9.67
gastric cancer cell line:AZ521	10549-107H9	277.74	19.18	2.30	0.66	0.66	27.05
gastric cancer cell line:GSS	10560-108A2	104.34	6.41	1.83	2.75	0.00	27.46
gastrointestinal carcinoma cell line:ECC12	10615-108G3	351.14	12.79	2.06	9.14	2.06	5.48
giant cell carcinoma cell line:LU65	10487-107B1	14.57	1.38	0.00	0.00	0.11	1.15
giant cell carcinoma cell line:Lu99B	10433-106E1	79.22	7.00	1.82	0.28	0.14	4.62
glassy cell carcinoma cell line:HOKUG	10688-109F4	112.24	6.24	1.25	1.00	0.00	3.49
glioblastoma cell line:A172, tech_rep1	10444-106F3	202.66	8.87	2.85	0.74	1.37	6.23
glioblastoma cell line:A172, tech_rep2	10444-106F3	202.37	8.99	4.07	0.84	1.54	4.49
glioblastoma cell line:T98G	10485-107A8	408.93	22.52	4.97	1.99	2.21	7.51
glioma cell line:GI-1	10413-106B8	129.45	9.37	0.88	0.29	0.59	3.81
globus pallidus - adult, donor10196	10175-103C4	42.28	5.10	0.00	2.19	0.00	5.83
globus pallidus, adult, donor10252	10161-103A8	65.91	5.37	0.24	0.24	0.00	7.08
globus pallidus, adult, donor10258	10367-105F7	27.38	5.48	0.00	0.00	0.00	8.22
globus pallidus, newborn, donor10223	10364-105F4	30.38	2.66	0.00	0.53	0.00	2.13
granulocyte macrophage progenitor, donor1	12131-128D7	1583.30	53.84	9.79	0.00	2.45	14.68
granulocyte macrophage progenitor, donor2	12135-128E2	568.28	10.93	10.93	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	559.24	26.13	0.00	0.00	5.23	15.68
granulosa cell tumor cell line:KGN	10624-108H3	91.84	6.72	1.60	1.28	0.00	4.48
hIPS +CCl2, biol_rep1	14383-156B9	226.80	13.77	0.46	3.67	0.00	26.17
hIPS +CCl2, biol_rep2	14384-156C1	211.71	8.69	0.91	3.66	0.00	32.01
hIPS +CCl2, biol_rep3	14385-156C2	248.62	7.09	0.00	5.15	0.00	21.90
hIPS, biol_rep1	14380-156B6	189.72	1.44	1.44	0.00	0.00	54.62
hIPS, biol_rep2	14381-156B7	196.16	5.49	0.00	6.17	0.00	33.61
hIPS, biol_rep3	14382-156B8	52.97	2.21	0.00	0.00	0.00	11.03
hairy cell leukemia cell line:Mo	10712-109I1	350.85	15.80	0.57	6.03	0.57	18.10
heart - mitral valve, adult	10205-103F7	67.27	3.89	1.49	0.60	0.30	7.77
heart - pulmonic valve, adult	10206-103F8	48.90	2.88	1.83	0.26	1.05	7.06
heart - tricuspid valve, adult	10207-103F9	79.10	0.83	0.83	0.00	0.00	4.16
heart, adult, diseased post-infarction, donor1	10050-101G5	158.96	16.32	2.24	5.92	0.20	9.59
heart, adult, diseased, donor1	10051-101G6	25.98	1.28	1.28	0.85	0.00	2.13
heart, adult, pool1	10016-101C7	95.90	3.68	0.46	0.23	0.23	4.60
heart, fetal, pool1	10046-101G1	259.16	9.75	1.75	0.21	2.05	11.19
hepatic mesenchymal tumor cell line:LI90	10778-110G4	9.56	0.93	0.00	0.00	0.00	1.85
hepatoblastoma cell line:HuH-6	10633-108I3	486.37	19.03	1.19	5.95	0.00	16.65
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	380.88	36.57	4.09	4.42	0.77	12.60
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	408.06	41.51	5.83	6.92	0.73	17.36
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	455.85	47.19	5.05	3.94	0.30	16.98
hepatoma cell line:Li-7	10484-107A7	60.84	1.33	0.11	0.33	0.11	0.67
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	556.47	37.08	2.51	3.92	0.60	30.85
hippocampus - adult, donor10196	10169-103B7	33.12	4.73	0.00	0.00	0.00	4.73
hippocampus, adult, donor10252	10153-102I9	41.02	5.31	1.02	1.02	0.20	7.96
hippocampus, adult, donor10258	10374-105G5	37.35	1.00	0.00	0.50	0.00	6.47
hippocampus, newborn, donor10223	10363-105F3	16.92	1.41	0.35	0.70	0.00	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	389.40	59.81	0.61	15.26	0.00	56.76
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	218.74	36.91	0.59	6.28	0.00	30.04
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	264.56	40.62	0.76	5.84	0.00	39.61
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	377.23	24.81	1.13	4.51	0.00	14.66
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	401.26	32.53	1.03	35.89	0.52	15.23
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	508.30	34.54	1.90	7.97	0.00	30.75
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	606.68	22.48	1.17	4.67	0.88	14.89
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	609.45	30.59	1.51	7.54	0.43	15.08
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	465.45	22.52	0.83	4.17	0.83	12.93
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	831.14	35.52	1.66	4.97	0.95	17.29
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	719.37	29.41	0.96	9.00	0.16	12.54
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	777.66	28.95	0.67	2.69	2.02	16.83
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	205.46	29.42	0.16	5.01	0.16	22.85
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	215.68	23.09	0.98	20.14	0.49	20.14
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	318.55	32.29	0.00	7.85	0.00	46.26
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	384.69	24.82	0.76	7.45	0.19	18.90
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	333.60	16.57	0.00	3.92	0.87	15.70
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	376.32	25.49	0.50	5.50	0.50	20.49
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	481.91	24.49	2.64	7.54	1.13	21.48
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	511.10	18.64	1.36	7.28	0.91	22.74
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	486.14	22.24	2.51	6.89	0.00	19.42
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	337.54	17.64	0.98	5.23	0.65	11.92
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	368.40	16.26	1.45	5.23	0.00	11.90
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	321.64	14.35	0.30	2.69	0.00	7.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	301.69	37.32	0.00	8.31	0.18	26.97
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	273.59	23.39	0.29	4.85	0.57	24.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	427.91	41.24	1.22	4.08	0.00	39.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	371.45	20.77	1.06	12.32	0.70	17.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	329.41	20.27	0.95	5.07	0.32	11.40
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	351.65	20.88	1.51	5.75	0.00	15.13
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	327.34	15.00	0.00	3.10	0.00	13.96
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	373.26	17.27	0.00	0.66	1.99	15.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	427.38	19.24	1.28	3.59	0.00	13.08
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	335.92	14.57	0.77	6.39	0.51	10.48
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	466.45	20.45	0.76	2.27	0.00	12.12
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	304.80	18.48	0.67	3.02	1.01	11.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	307.20	30.91	1.69	7.00	0.00	23.18
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	341.82	42.34	0.45	7.13	0.00	31.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	330.73	29.27	1.95	5.37	0.49	25.37
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	389.36	22.62	0.61	6.11	0.61	16.50
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	3386.63	191.94	6.51	87.84	0.00	146.40
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	579.48	38.72	0.99	4.30	0.99	30.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	521.03	25.18	0.55	6.02	0.55	15.87
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	580.10	24.25	0.36	6.51	0.00	17.73
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	531.67	23.13	1.07	4.98	0.36	13.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	409.33	23.87	0.00	9.55	0.00	16.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	624.72	28.03	1.35	3.52	0.54	14.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	377.69	17.51	1.89	1.89	0.81	11.85
immature langerhans cells, donor1	11904-125F5	113.57	5.81	0.48	0.48	0.00	7.02
immature langerhans cells, donor2	11905-125F6	83.17	3.96	0.00	0.00	0.00	5.54
insula, adult, pool1	10039-101F3	28.67	2.93	0.00	0.19	0.09	4.45
keratoacanthoma cell line:HKA-1	10791-110H8	172.65	16.26	3.25	1.63	0.00	5.20
kidney, adult, pool1	10017-101C8	52.77	4.21	0.70	0.30	0.60	3.70
kidney, fetal, pool1	10045-101F9	76.75	5.23	0.85	0.14	0.28	7.29
large cell lung carcinoma cell line:IA-LM	10509-107D5	103.96	6.11	0.00	0.43	0.00	4.97
large cell lung carcinoma cell line:NCI-H460	10839-111E2	25.02	0.55	0.00	0.14	0.00	1.24
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	147.72	9.91	1.28	0.18	0.18	4.77
left atrium, adult, donor1	10079-102A7	27.24	3.27	0.00	0.00	0.54	2.72
left ventricle, adult, donor1	10078-102A6	85.96	1.01	0.51	0.51	0.00	4.05
leiomyoblastoma cell line:G-402	10721-110A1	162.52	11.49	0.55	1.37	0.55	6.02
leiomyoma cell line:10964C	10569-108B2	30.54	1.08	0.36	1.08	0.00	0.72
leiomyoma cell line:15242A	10570-108B3	10.87	0.00	0.00	0.00	0.00	1.09
leiomyoma cell line:15425	10571-108B4	43.71	3.40	0.49	1.46	0.24	2.19
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	6.35	0.00	0.00	0.00	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	196.56	7.32	1.05	2.09	1.05	4.18
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	458.66	17.94	0.24	3.78	0.24	5.19
liposarcoma cell line:KMLS-1	10782-110G8	42.18	2.03	0.78	0.16	0.00	3.44
liposarcoma cell line:SW 872	10726-110A6	255.98	10.11	1.71	1.22	0.73	4.02
liver, adult, pool1	10018-101C9	16.53	0.81	0.32	0.16	0.00	0.49
liver, fetal, pool1	10086-102B5	142.99	6.58	4.70	4.70	0.00	2.82
locus coeruleus - adult, donor10196	10182-103D2	38.21	3.65	0.15	0.15	0.29	4.96
locus coeruleus, adult, donor10252	10165-103B3	37.09	3.32	0.55	0.37	0.00	4.06
locus coeruleus, adult, donor10258	10375-105G6	18.06	1.13	0.00	0.00	0.00	3.67
locus coeruleus, newborn, donor10223	10362-105F2	38.28	2.94	0.42	0.84	0.00	3.36
lung adenocarcinoma cell line:A549	10499-107C4	40.27	2.91	0.42	0.00	0.00	2.35
lung adenocarcinoma cell line:PC-14	10408-106B3	179.93	20.68	2.76	0.00	0.69	12.41
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	319.00	29.66	5.01	2.50	0.40	22.80
lung, adult, pool1	10019-101D1	125.45	7.91	1.42	0.59	0.95	5.91
lung, fetal, donor1	10068-101I5	361.90	5.99	4.00	0.29	1.43	29.40
lung, right lower lobe, adult, donor1	10075-102A3	33.45	1.37	0.92	0.92	0.46	4.58
lymph node, adult, donor1	10077-102A5	88.52	3.31	0.47	2.37	0.47	2.84
lymphangiectasia cell line:DS-1	10727-110A7	174.68	19.95	0.44	1.53	0.22	13.15
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	867.83	113.35	12.98	4.68	4.53	76.67
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	273.54	20.39	0.85	1.70	0.00	8.49
mature adipocyte, donor1	12231-129F8	67.93	2.66	0.44	0.00	0.89	1.78
mature adipocyte, donor2	12232-129F9	45.03	2.49	1.04	0.21	0.83	2.70
mature adipocyte, donor3	12233-129G1	44.80	0.95	0.71	0.24	0.24	1.42
mature adipocyte, donor4	12234-129G2	82.12	2.90	1.05	0.00	0.79	2.90
maxillary sinus tumor cell line:HSQ-89	10414-106B9	164.16	16.68	1.91	0.71	0.24	16.68
medial frontal gyrus - adult, donor10196	10170-103B8	36.10	6.77	1.13	0.00	0.00	4.51
medial frontal gyrus, adult, donor10252	10150-102I6	38.80	5.89	0.74	0.37	0.18	5.15
medial frontal gyrus, adult, donor10258	10368-105F8	22.24	1.27	0.00	0.64	0.00	3.49
medial frontal gyrus, newborn, donor10223	10352-105E1	50.33	2.13	0.00	3.84	0.43	2.13
medial temporal gyrus - adult, donor10196	10183-103D3	40.50	7.43	0.17	4.56	0.00	5.40
medial temporal gyrus, adult, donor10252	10156-103A3	37.14	5.09	1.27	0.42	0.21	5.73
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	21.19	1.93	0.00	0.00	0.00	11.56
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	272.72	28.71	0.00	0.00	0.00	28.71
medial temporal gyrus, newborn, donor10223	10353-105E2	38.76	1.44	0.72	0.36	0.36	0.72
medulla oblongata - adult, donor10196	10174-103C3	52.57	4.54	0.00	0.00	0.00	3.89
medulla oblongata, adult, donor10252	10155-103A2	52.94	5.73	0.15	0.46	0.15	5.26
medulla oblongata, adult, pool1	10038-101F2	47.59	3.18	0.57	0.33	0.16	5.39
medulla oblongata, newborn, donor10223	10361-105F1	39.58	3.47	0.00	0.69	0.00	2.43
medulloblastoma cell line:D283 Med	10838-111E1	873.47	60.00	9.52	17.93	14.83	34.76
medulloblastoma cell line:ONS-76	10759-110E3	138.41	8.31	0.73	1.47	0.24	5.26
melanoma cell line:COLO 679	10514-107E1	109.39	9.92	0.57	0.14	0.29	3.88
melanoma cell line:G-361	10465-106H6	27.69	1.63	0.00	0.27	0.00	2.44
meningioma cell line:HKBMM	10691-109F7	36.54	3.08	0.36	1.63	0.18	2.53
merkel cell carcinoma cell line:MKL-1	10843-111E6	1528.81	110.14	28.20	23.79	37.01	29.96
merkel cell carcinoma cell line:MS-1	10844-111E7	1086.66	85.03	13.74	12.44	10.63	31.11
mesenchymal precursor cell - adipose, donor1	11747-123G1	82.24	2.15	1.23	0.61	0.00	4.30
mesenchymal precursor cell - adipose, donor2	11748-123G2	66.53	2.00	0.73	0.18	0.00	2.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	44.72	0.41	0.41	0.41	0.00	2.48
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	47.76	1.83	0.14	0.28	0.00	1.40
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	32.54	2.12	0.58	0.39	0.58	1.35
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	28.46	2.78	0.00	0.69	0.00	2.08
mesenchymal precursor cell - cardiac, donor1	11752-123G6	12.70	0.69	0.17	0.17	0.00	1.37
mesenchymal precursor cell - cardiac, donor2	11753-123G7	20.13	0.46	0.12	0.23	0.12	0.46
mesenchymal precursor cell - cardiac, donor3	11754-123G8	63.00	3.85	0.66	0.53	0.27	2.79
mesenchymal precursor cell - cardiac, donor4	11755-123G9	98.31	4.32	1.76	1.22	0.95	2.57
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	44.81	3.56	1.14	0.14	0.57	2.42
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	10.21	1.32	0.33	0.00	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	48.15	3.46	0.83	0.69	0.00	2.77
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	32.81	2.79	0.70	1.40	0.00	2.09
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	17.15	0.41	0.41	0.00	0.00	2.65
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	10.78	1.44	0.36	0.36	0.00	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	13.45	0.31	0.31	0.10	0.00	1.34
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	5.70	0.46	0.00	0.00	0.00	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	175.79	4.20	1.26	2.10	0.00	10.49
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	29.29	1.64	0.15	0.60	0.30	1.79
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	27.31	0.70	0.09	0.35	0.09	1.23
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	18.04	0.00	0.37	0.37	0.37	4.05
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	18.60	1.14	0.00	0.29	0.00	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	414.28	23.58	6.74	20.21	3.37	15.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	42.93	0.46	0.00	0.00	0.00	3.20
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	47.06	3.58	0.26	0.77	0.00	1.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	55.75	4.45	0.26	0.52	0.52	1.83
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	43.44	3.39	0.00	0.92	0.31	3.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	52.25	4.00	0.00	0.94	0.24	1.88
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	48.06	3.38	0.34	1.02	0.34	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	47.55	6.29	0.00	1.57	0.00	1.96
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	46.80	1.85	0.00	0.46	0.00	3.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	193.21	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	68.35	4.04	0.00	1.44	0.00	2.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	56.44	3.35	0.67	0.45	0.00	2.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	62.49	4.09	0.00	0.48	0.24	2.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	78.47	2.20	0.00	1.47	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	61.76	1.68	0.67	0.67	0.34	2.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	63.86	3.68	0.41	0.41	0.00	3.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	68.30	2.58	0.00	1.72	0.00	2.58
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	46.48	5.47	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	87.80	5.16	0.00	0.00	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	73.08	3.90	0.32	0.65	0.00	4.55
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	62.56	1.45	1.45	0.00	0.00	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	50.64	2.67	1.07	1.07	0.00	3.20
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	52.34	3.27	0.00	0.00	0.00	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	62.58	3.89	0.39	1.17	0.00	1.94
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	44.07	4.20	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	54.64	0.99	0.00	0.00	0.00	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	61.97	4.77	0.00	4.77	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	64.04	2.37	0.00	1.78	0.00	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	75.54	2.44	0.00	0.00	0.00	3.66
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	81.16	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	65.24	2.53	0.00	2.53	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	56.22	2.76	0.00	0.00	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	53.73	0.00	0.00	0.00	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	27.94	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	34.44	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	37.49	1.22	0.41	1.63	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	32.57	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	27.12	1.77	0.00	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	29.61	1.56	0.00	0.00	0.00	1.56
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	26.73	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	10.64	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	15.41	0.00	0.00	0.00	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	24.09	0.00	0.00	0.69	0.00	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	7.92	0.99	0.00	0.00	0.49	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	3.36	0.00	0.00	0.00	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	8.90	0.64	0.64	0.00	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	2.82	0.00	0.00	0.40	0.00	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	2.18	2.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	6.34	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	14.57	1.21	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	27.11	0.00	0.00	0.00	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	17.30	0.00	1.65	1.65	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	11.91	1.59	0.00	0.00	0.00	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	8.44	0.97	0.00	0.00	0.00	0.97
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	19.35	2.04	0.00	1.02	0.00	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	73.50	6.19	0.77	0.77	0.00	3.87
mesothelioma cell line:ACC-MESO-1	10493-107B7	30.00	5.67	0.94	0.24	0.00	7.32
mesothelioma cell line:ACC-MESO-4	10494-107B8	257.16	10.19	2.32	0.46	0.93	4.40
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	354.71	8.55	4.27	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	266.53	10.58	0.51	2.88	0.41	1.64
mesothelioma cell line:Mero-25	10850-111F4	120.06	2.95	0.68	0.91	0.45	0.68
mesothelioma cell line:Mero-41	10851-111F5	134.46	6.85	1.96	2.44	0.24	7.09
mesothelioma cell line:Mero-48a	10852-111F6	58.68	2.88	0.22	1.11	0.22	3.10
mesothelioma cell line:Mero-82	10853-111F7	260.18	6.83	0.26	8.67	0.00	2.10
mesothelioma cell line:Mero-83	10854-111F8	149.45	4.09	0.34	1.36	0.34	1.70
mesothelioma cell line:Mero-84	10855-111F9	81.65	2.53	1.52	0.25	0.76	2.27
mesothelioma cell line:Mero-95	10856-111G1	133.34	4.97	1.24	0.62	0.00	2.69
mesothelioma cell line:NCI-H2052	10847-111F1	166.64	9.28	1.66	2.65	0.66	8.28
mesothelioma cell line:NCI-H226	10846-111E9	175.38	5.79	1.63	2.35	0.54	2.17
mesothelioma cell line:NCI-H2452	10848-111F2	128.46	5.98	1.54	1.88	0.51	3.07
mesothelioma cell line:NCI-H28	10845-111E8	154.21	5.85	1.78	1.53	0.25	6.87
mesothelioma cell line:No36	10857-111G2	106.02	5.87	0.65	1.96	0.00	0.65
mesothelioma cell line:ONE58	10858-111G3	94.02	4.06	0.81	0.81	0.00	2.44
migratory langerhans cells, donor1	11901-125F2	87.13	4.22	0.38	0.58	0.00	18.23
migratory langerhans cells, donor2	11902-125F3	26.87	2.08	0.24	0.24	0.00	6.11
migratory langerhans cells, donor3	11903-125F4	89.20	6.46	0.00	0.36	0.00	12.03
mixed mullerian tumor cell line:HTMMT	10689-109F5	88.48	7.84	0.33	2.61	0.33	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	80.96	8.27	0.64	1.27	0.00	3.39
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	216.31	7.37	0.23	0.00	0.00	4.61
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	285.44	15.03	1.33	2.85	0.19	20.17
myelodysplastic syndrome cell line:SKM-1	10772-110F7	1334.20	48.60	4.07	6.65	1.29	18.85
myeloma cell line:PCM6	10474-106I6	157.94	20.76	3.16	0.99	0.79	13.05
myxofibrosarcoma cell line:MFH-ino	10600-108E6	272.92	17.25	2.54	0.51	0.00	9.64
myxofibrosarcoma cell line:NMFH-1	10684-109E9	98.46	6.28	0.39	0.59	0.20	3.33
nasal epithelial cells, donor1, tech_rep1	12226-129F3	34.21	1.00	0.00	0.11	0.00	1.34
nasal epithelial cells, donor1, tech_rep2	12226-129F3	35.67	0.88	0.00	0.07	0.07	1.25
nasal epithelial cells, donor2	12227-129F4	43.06	16.56	0.00	1.66	0.00	4.97
neuroblastoma cell line:CHP-134	10508-107D4	960.04	35.43	1.84	2.07	0.92	15.41
neuroblastoma cell line:NB-1	10539-107G8	496.90	31.99	4.49	1.50	1.50	13.28
neuroblastoma cell line:NBsusSR	10607-108F4	307.05	14.55	1.69	4.85	0.84	6.33
neuroblastoma cell line:NH-12	10555-107I6	844.36	35.59	2.05	7.83	2.05	17.89
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	356.79	15.66	1.90	10.91	0.71	7.12
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	249.61	13.46	1.11	2.85	0.32	5.70
neuroectodermal tumor cell line:TASK1	10774-110F9	228.63	7.65	1.01	2.42	0.20	3.82
neuroepithelioma cell line:SK-N-MC	10728-110A8	375.10	27.97	2.54	0.64	0.00	17.17
neurofibroma cell line:Hs 53.T	10729-110A9	48.44	2.40	0.27	0.80	0.27	1.06
neutrophil PMN, donor1	12133-128D9	1487.48	14.87	59.50	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	1739.77	0.00	13.28	0.00	0.00	13.28
neutrophil PMN, donor3	12141-128E8	1363.77	9.47	9.47	9.47	9.47	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	2877.92	291.56	17.25	13.19	6.76	131.24
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	190.52	10.41	1.60	1.60	1.60	4.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	43.60	2.89	0.32	0.00	0.00	1.28
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	45.98	2.89	0.53	1.31	0.26	1.58
nucleus accumbens, adult, pool1	10037-101F1	37.21	3.00	0.47	0.00	0.19	6.00
occipital cortex - adult, donor10196	10172-103C1	45.33	2.06	0.00	0.00	0.00	8.24
occipital cortex, adult, donor10252	10163-103B1	56.62	5.64	0.81	0.54	0.00	5.10
occipital cortex, newborn, donor10223	10355-105E4	36.76	3.64	0.73	0.73	1.09	1.46
occipital lobe, adult, donor1	10076-102A4	24.40	2.10	0.00	0.00	0.00	4.99
occipital lobe, fetal, donor1	10073-102A1	53.64	3.43	0.00	0.43	0.43	2.57
occipital pole, adult, pool1	10036-101E9	27.44	1.42	0.00	0.16	0.00	2.44
olfactory region, adult	10195-103E6	28.28	4.39	0.00	0.57	0.00	5.92
optic nerve, donor1	10277-104E7	92.05	2.00	0.00	0.00	0.00	10.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	97.96	5.58	0.34	0.34	0.11	2.05
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	109.63	6.46	0.69	0.69	0.00	7.83
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	197.94	9.65	1.86	4.91	0.85	3.39
oral squamous cell carcinoma cell line:SAS	10544-107H4	201.33	12.82	1.04	2.89	0.12	7.74
osteoclastoma cell line:Hs 706.T	10704-109H2	91.72	0.88	0.29	1.18	0.00	2.35
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	438.20	21.49	0.00	0.93	0.00	7.47
osteosarcoma cell line:HS-Os-1	10558-107I9	160.32	13.15	1.27	0.21	0.00	3.61
ovary, adult, pool1	10020-101D2	97.66	5.15	0.52	0.35	0.52	9.52
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	116.78	5.68	0.37	1.65	0.00	4.95
pancreas, adult, donor1	10049-101G4	21.63	0.00	0.00	0.00	0.00	2.82
pancreatic carcinoma cell line:NOR-P1	10698-109G5	283.45	10.06	0.84	4.47	0.28	6.15
papillary adenocarcinoma cell line:8505C	10437-106E5	290.45	12.61	1.53	7.15	0.34	2.38
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	174.36	10.60	1.66	0.33	0.00	7.95
paracentral gyrus, adult, pool1	10035-101E8	29.38	1.37	0.00	0.00	0.09	4.48
parietal cortex, adult, donor10258	10373-105G4	17.62	5.87	0.00	3.67	0.00	6.61
parietal lobe - adult, donor10196	10171-103B9	27.27	3.76	0.00	0.00	0.00	5.64
parietal lobe, adult, donor10252	10157-103A4	41.62	3.42	0.29	0.29	0.00	5.70
parietal lobe, adult, pool1	10034-101E7	29.61	2.82	0.18	0.09	0.00	3.97
parietal lobe, fetal, donor1	10072-101I9	118.32	7.76	0.00	1.94	0.97	2.91
parietal lobe, newborn, donor10223	10356-105E5	39.26	2.62	0.37	0.75	0.75	1.87
parotid gland, adult	10199-103F1	17.88	2.47	0.62	0.62	0.00	4.32
penis, adult	10200-103F2	43.51	3.22	0.00	1.61	0.54	9.13
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	178.87	6.88	0.37	4.09	0.19	5.58
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	66.58	4.08	1.60	0.58	0.29	3.21
pineal gland - adult, donor10196	10179-103C8	69.02	2.58	0.00	0.00	0.00	12.90
pineal gland, adult, donor10252	10160-103A7	90.02	6.51	1.18	0.59	0.00	17.17
pineal gland, adult, donor10258	10377-105G8	35.12	3.14	0.00	0.63	0.00	10.66
pituitary gland - adult, donor10196	10180-103C9	45.53	4.05	0.00	1.01	0.00	13.15
pituitary gland, adult, donor10252	10162-103A9	37.52	1.56	0.52	1.04	0.52	6.78
pituitary gland, adult, donor10258	10378-105G9	17.02	2.55	0.00	0.00	0.00	11.92
placenta, adult, pool1	10021-101D3	63.00	3.12	0.75	0.22	0.43	4.09
plasma cell leukemia cell line:ARH-77	10840-111E3	449.46	51.51	3.71	5.56	0.53	63.56
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	115.64	10.12	3.27	0.47	1.09	4.51
pons, adult, pool1	10033-101E6	33.57	3.87	0.17	0.09	0.17	6.11
postcentral gyrus, adult, pool1	10032-101E5	33.48	2.96	0.09	0.26	0.17	4.10
promyelocytes/myelocytes PMC, donor1	12132-128D8	1635.47	31.37	12.55	0.00	0.00	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	820.70	22.03	27.54	22.03	0.00	5.51
promyelocytes/myelocytes PMC, donor3	12140-128E7	833.24	46.94	11.74	0.00	0.00	23.47
prostate cancer cell line:DU145	10490-107B4	94.10	9.61	1.17	0.44	0.15	7.57
prostate cancer cell line:PC-3	10439-106E7	225.06	22.87	1.63	1.82	0.54	8.35
prostate, adult, pool1	10022-101D4	77.63	4.26	0.54	0.27	0.45	7.07
putamen, adult, donor10196	10176-103C5	45.80	6.85	0.00	0.24	0.00	8.26
putamen, adult, donor10252	10152-102I8	52.94	1.96	0.00	0.00	0.00	7.84
putamen, adult, donor10258, tech_rep1	10372-105G3	81.96	2.19	0.00	1.09	0.00	9.84
putamen, adult, donor10258, tech_rep2	10372-105G3	30.20	3.14	0.48	0.24	0.24	5.56
putamen, newborn, donor10223	10365-105F5	51.73	10.50	0.00	0.75	0.00	3.75
rectal cancer cell line:TT1TKB	10469-106I1	240.02	9.60	0.29	1.45	0.00	6.11
rectum, fetal, donor1	10067-101I4	173.87	18.08	1.39	1.39	6.95	13.91
renal cell carcinoma cell line:OS-RC-2	10411-106B6	82.68	5.72	2.12	0.64	0.85	8.27
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	187.22	21.54	0.00	1.24	0.00	26.92
retina, adult, pool1	10030-101E3	61.73	4.17	0.40	0.20	0.40	5.37
retinoblastoma cell line:Y79	10475-106I7	950.62	55.86	11.95	7.53	5.20	30.92
rhabdomyosarcoma cell line:KYM-1	10787-110H4	444.58	33.81	1.60	2.95	0.86	15.61
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	1064.34	81.83	15.75	4.78	4.50	46.40
sacrococcigeal teratoma cell line:HTST	10695-109G2	77.30	2.27	0.00	0.00	0.00	3.79
salivary acinar cells, donor1	11771-123I7	37.07	1.94	0.16	0.32	0.00	0.97
salivary acinar cells, donor2	11772-123I8	44.75	1.51	0.00	0.83	0.41	2.20
salivary acinar cells, donor3	11773-123I9	43.03	1.32	0.66	0.00	0.00	1.99
salivary gland, adult, pool1	10093-102C3	34.89	1.72	0.00	0.00	0.00	1.72
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	64.33	2.87	0.42	0.34	0.08	3.12
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	64.77	3.29	0.59	0.35	0.00	2.35
seminal vesicle, adult	10201-103F3	33.33	4.23	0.53	0.53	0.00	3.70
serous adenocarcinoma cell line:JHOS-2	10639-108I9	73.85	6.07	1.21	1.21	0.73	3.64
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	54.60	1.76	1.26	0.50	0.00	3.52
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	110.39	12.04	2.01	1.00	0.00	8.03
serous cystadenocarcinoma cell line:HTOA	10693-109F9	77.37	4.16	0.40	0.67	0.00	2.42
signet ring carcinoma cell line:Kato III	10436-106E4	522.69	18.68	3.54	1.22	0.33	6.41
signet ring carcinoma cell line:NUGC-4	10483-107A6	317.27	11.48	3.35	1.55	0.39	8.77
skeletal muscle - soleus muscle, donor1	10282-104F3	191.52	2.13	0.00	1.42	0.00	13.48
skeletal muscle, adult, pool1	10023-101D5	94.99	2.76	0.12	0.12	0.60	4.92
skeletal muscle, fetal, donor1	10066-101I3	14.07	1.01	0.00	0.00	1.01	3.02
skin, adult, donor1	10074-102A2	27.14	0.00	0.00	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	89.00	10.73	1.89	0.00	2.52	3.79
small cell cervical cancer cell line:HCSC-1	10800-110I8	382.88	26.35	15.68	3.34	5.67	12.34
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	524.19	40.66	5.36	12.61	2.84	15.76
small cell lung carcinoma cell line:DMS 144	10841-111E4	126.83	18.89	2.70	2.89	0.00	56.67
small cell lung carcinoma cell line:LK-2	10541-107H1	634.91	26.04	3.96	0.99	0.33	12.36
small cell lung carcinoma cell line:NCI-H82	10842-111E5	944.19	70.93	7.40	15.60	5.47	91.68
small cell lung carcinoma cell line:WA-hT	10562-108A4	497.94	22.66	5.88	5.01	1.09	11.55
small intestine, adult, pool1	10024-101D6	98.30	7.05	0.84	0.48	0.24	4.06
small intestine, fetal, donor1	10064-101I1	116.71	9.34	2.70	2.46	0.49	4.91
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	59.50	4.10	2.05	2.05	0.00	3.08
smooth muscle, adult, pool1	10048-101G3	92.01	2.33	0.00	2.33	0.00	4.39
somatostatinoma cell line:QGP-1	10781-110G7	52.00	1.61	0.27	0.00	0.00	2.41
spinal cord - adult, donor10196	10181-103D1	53.45	5.28	0.23	1.38	0.00	5.74
spinal cord, adult, donor10252	10159-103A6	71.76	5.52	0.39	1.18	0.00	3.55
spinal cord, adult, donor10258	10369-105F9	57.42	1.38	0.00	0.69	0.00	8.99
spinal cord, fetal, donor1	10056-101H2	57.32	5.49	0.61	0.00	0.00	3.66
spinal cord, newborn, donor10223	10359-105E8	55.11	2.76	0.46	0.46	0.46	4.13
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	107.39	3.88	0.90	0.60	0.00	3.14
spleen, adult, pool1	10025-101D7	99.12	8.70	2.31	0.33	2.75	6.61
spleen, fetal, pool1	10044-101F8	160.90	7.79	4.05	0.16	1.91	7.23
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	202.16	27.12	2.79	2.28	0.72	26.40
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	94.56	5.89	0.00	0.19	0.19	3.61
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	378.11	31.80	2.10	13.28	0.70	29.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	71.15	3.91	0.00	1.17	0.00	1.95
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	72.71	1.80	0.45	0.11	0.23	2.14
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	101.24	5.93	1.69	1.27	0.00	7.20
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	403.19	26.23	2.96	2.54	1.27	18.62
stomach, fetal, donor1	10062-101H8	122.82	10.68	0.00	0.00	2.14	7.48
submaxillary gland, adult	10202-103F4	17.09	2.85	0.57	0.00	0.57	2.85
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	49.85	5.61	0.42	0.42	0.00	5.19
substantia nigra, adult, donor10258	10371-105G2	35.69	0.00	0.00	0.00	0.00	5.17
substantia nigra, newborn, donor10223	10358-105E7	21.90	1.41	0.00	0.00	0.00	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	309.74	31.18	4.36	3.90	0.00	32.10
temporal lobe, adult, pool1	10031-101E4	18.99	1.53	0.25	0.17	0.00	2.97
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	61.25	2.14	0.71	1.42	0.71	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	67.25	4.83	1.76	0.44	0.44	3.08
tenocyte, donor1	11763-123H8	85.88	6.63	0.70	1.05	0.70	1.75
tenocyte, donor2	11765-123I1	56.84	2.67	0.38	1.91	0.00	1.91
tenocyte, donor3	11768-123I4	42.26	2.97	1.11	1.48	0.00	2.59
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	284.85	13.09	0.85	5.78	0.34	23.62
teratocarcinoma cell line:NCR-G1	10798-110I6	369.18	13.72	2.00	4.47	0.46	6.01
teratocarcinoma cell line:PA-1	10807-111A6	341.57	24.49	0.31	2.94	0.15	18.29
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	202.74	12.57	0.13	2.67	0.25	6.22
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	343.38	29.88	1.51	3.40	0.38	37.82
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	142.87	8.07	0.33	0.65	0.00	12.43
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	759.21	40.71	0.65	39.08	0.33	19.54
testis, adult, pool1	10026-101D8	102.11	10.52	0.97	0.43	0.64	13.74
testis, adult, pool2	10096-102C6	156.98	13.08	0.45	9.92	0.45	21.20
thalamus - adult, donor10196	10168-103B6	45.26	7.73	0.00	0.00	0.00	6.62
thalamus, adult, donor10252	10154-103A1	52.82	7.97	0.63	0.16	0.16	3.75
thalamus, adult, donor10258, tech_rep1	10370-105G1	12.32	0.00	0.00	0.00	0.00	12.32
thalamus, adult, donor10258, tech_rep2	10370-105G1	16.96	0.99	0.00	0.16	0.00	2.96
thalamus, newborn, donor10223	10366-105F6	30.49	1.73	0.00	0.58	0.00	2.88
throat, adult	10209-103G2	95.37	6.99	2.25	0.25	1.00	7.74
throat, fetal, donor1	10061-101H7	145.34	12.19	1.83	2.44	2.13	8.84
thymic carcinoma cell line:Ty-82	10803-111A2	305.65	27.23	4.17	1.39	1.59	29.41
thymus, adult, pool1	10027-101D9	887.58	23.26	5.67	2.78	3.38	6.76
thymus, fetal, pool1	10043-101F7	1099.83	30.24	6.13	3.53	4.36	9.87
thyroid carcinoma cell line:KHM-5M	10776-110G2	242.25	17.42	0.80	2.39	0.00	4.79
thyroid carcinoma cell line:TCO-1	10783-110G9	306.34	16.48	1.82	3.07	0.56	6.57
thyroid, adult, pool1	10028-101E1	85.29	5.13	0.47	0.65	0.09	6.63
thyroid, fetal, donor1	10060-101H6	45.88	2.64	0.79	1.05	1.05	5.01
tongue epidermis (fungiform papillae), donor1	10288-104F9	157.06	6.16	3.08	0.00	0.00	3.08
tongue, adult	10203-103F5	81.40	3.72	0.93	2.33	0.93	4.42
tongue, fetal, donor1	10059-101H5	59.90	5.12	1.18	0.79	0.79	6.31
tonsil, adult, pool1	10047-101G2	181.62	18.73	2.30	0.20	0.70	13.02
trachea, adult, pool1	10029-101E2	70.26	3.27	0.90	0.25	0.65	4.66
trachea, fetal, donor1	10058-101H4	80.02	5.77	0.38	1.92	1.54	6.16
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	131.79	4.96	0.71	2.48	0.35	3.19
transitional-cell carcinoma cell line:5637	10418-106C4	275.88	18.44	3.55	0.61	0.71	7.90
transitional-cell carcinoma cell line:JMSU1	10492-107B6	544.80	59.23	4.70	5.95	1.57	21.62
tridermal teratoma cell line:HGRT	10694-109G1	331.04	9.51	1.90	0.00	0.00	3.81
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	31.83	1.44	0.51	0.17	0.00	1.27
umbilical cord, fetal, donor1	10057-101H3	91.81	10.43	2.09	2.09	2.09	6.26
uterus, adult, pool1	10100-102D1	98.11	0.85	1.02	0.34	0.51	9.73
uterus, fetal, donor1	10055-101H1	186.85	18.43	2.05	2.05	2.05	9.73
vagina, adult	10204-103F6	63.33	2.58	0.00	0.00	0.00	3.88
vein, adult	10191-103E2	154.53	5.48	1.53	1.32	1.10	7.89
xeroderma pigentosum b cell line:XPL 17	10563-108A5	104.68	12.02	1.07	1.34	0.00	16.56